#33 - Rudy Leibel, M.D.: Finding the obesity gene and discovering leptin
Episode Stats
Length
2 hours and 20 minutes
Words per Minute
157.88351
Summary
Dr. Rudy Leibel is a professor at Columbia University, where his work has focused primarily on Type 2 Diabetes and obesity. In this episode, we discuss the discovery of leptin, the genetics of obesity, and the regulation of obesity.
Transcript
00:00:00.000
Hey everyone, welcome to the Peter Atiyah Drive. I'm your host, Peter Atiyah.
00:00:10.140
The Drive is a result of my hunger for optimizing performance, health, longevity, critical thinking,
00:00:15.600
along with a few other obsessions along the way. I've spent the last several years working with
00:00:19.840
some of the most successful, top-performing individuals in the world, and this podcast
00:00:23.620
is my attempt to synthesize what I've learned along the way to help you live a higher quality,
00:00:28.360
more fulfilling life. If you enjoy this podcast, you can find more information on today's episode
00:00:41.260
Hey, welcome to this episode of The Drive. On this episode, I interview an amazing scientist and a
00:00:47.480
very dear friend, Dr. Rudy Leibel. Rudy's a professor at Columbia University, where his work has focused
00:00:56.300
primarily on type 2 diabetes and obesity. I've known Rudy for quite a while, probably about six
00:01:03.020
years now, maybe a little longer. We worked together very closely back at the Nutrition Science Initiative,
00:01:09.240
where he was one of the very important collaborators in one of the more theoretical experiments that we
00:01:14.980
did. Rudy and I have always just had a ton of fun just hanging out over great meals and great wine and
00:01:20.880
great beer talking about science. And so I thought it might be fun to try to reproduce some of those
00:01:26.900
discussions here. A couple of things. First, we recorded this on a Friday afternoon on the Upper East
00:01:33.080
Side, and you'll probably notice a little more noise than usual just on account of the street noise. So
00:01:39.560
apologies for that. Second point is, we spend quite a bit of time, probably about the first hour and
00:01:46.000
10 hour and 15 minutes, just talking about the discovery of leptin, for which Rudy played arguably
00:01:54.000
the single most important role. Obviously, many people played a role in the discovery of leptin. But
00:01:58.880
you know, in many ways, Rudy was sort of the chief architect of that. And certainly inside of the
00:02:03.500
scientific community, he is largely regarded as that, though, unfortunately, history may write that
00:02:10.160
story a little bit differently. So for those of you listening to this who don't really,
00:02:14.320
really get off on geeky science and knowing the nuts and bolts of all of the experiments and how
00:02:20.320
one found this gene and the difference between a southern blot and a northern blot and a DNA sequence,
00:02:26.480
you might just want to skip to about an hour 15 when we get to the other stuff. But that said,
00:02:32.340
if you really are interested in science, I think there's a lot to be gained from listening to these
00:02:36.420
discussions because, you know, that's certainly something I plan to do a lot of as interview scientists.
00:02:41.260
And part of that is kind of understanding their stories. Again, a lot of what we talk about in
00:02:45.180
this post is technical. I'm hopeful that in the show notes, we'll be able to provide a lot of sort
00:02:49.940
of the necessary glossary to make it a little easier to ingest. I don't do a great job. I apologize
00:02:55.020
of trying to clarify terms. Occasionally, I remember that not everybody knows what hyperphagia means.
00:03:01.340
And I explained that that means eating too much. But again, I apologize for that. And just look to the
00:03:06.280
show notes if you want clarification on anything. We get into a lot of discussion around obesity,
00:03:11.440
the genetics of obesity and the regulation of obesity. How much of this is regulated centrally,
00:03:16.160
meaning in the brain, versus peripherally, everywhere outside of the brain. We talk a lot
00:03:20.500
about energy expenditure. And for those of you who are really interested in this science,
00:03:24.460
Rudy gives a great explanation of the two techniques that are used to measure energy expenditure,
00:03:28.420
known as indirect calorimetry and doubly labeled water. We talk about a number of genes that are
00:03:33.840
known to predispose to obesity, some very acutely and some very crudely, like the FTO gene. And we,
00:03:40.540
of course, talk a lot about insulin resistance, which in many ways is sort of a bit of a paradox,
00:03:45.040
because on the one hand, if you're insulin resistant, you technically shouldn't be able
00:03:48.460
to get fat. But of course, many insulin resistant people are able to get fat. They do accumulate
00:03:53.440
adipose tissue. What else can I say about this? I guess those are kind of the most important things
00:03:57.820
I'd say to guide you. So in summary, if you really don't want to hear about how leptin was
00:04:01.800
discovered, skip to an hour 15. If you do sit back and relax. The other highlight of this was,
00:04:07.900
it was the first time I ever gave Rudy a Topo Chico. He loved it. And I think I've got another
00:04:13.320
convert. So anyway, hope you enjoy this. And without further ado, here is my lovely discussion
00:04:28.680
Thanks so much for trekking over to the east side.
00:04:35.460
This will be one of the first times in a while that we hang out without a drink,
00:04:39.880
including my favorite beer, which you're one of the few people I've shared it with.
00:04:46.140
I don't tell anybody what that beer is because I, and I just found 19 bottles of it in Florida
00:04:52.360
last week. So I'm pretty psyched about that. I'll continue to share with you, of course.
00:04:59.380
No, it's actually in San Diego right now. Yeah, it just arrived. There's so much I want to talk
00:05:04.100
about. I almost don't even know where to begin. I'm guessing that a number of the people listening
00:05:08.140
to this won't actually know who you are necessarily, but I think by the end of this,
00:05:12.320
they'll be super interested in learning more about you. During the introduction, I will have
00:05:17.900
explained sort of a lot of stuff about you, but tell me a little bit about what you do and,
00:05:24.580
I've been very interested since the past 30 years or so in biology of the regulation of body weight
00:05:34.180
in both animals and humans. But the studies of animals are designed primarily to shed light on
00:05:43.760
what's the basis for the control of body weight in humans. I'm a physician and have been interested
00:05:49.840
in the clinical problem of obesity for even longer than I've been doing research on it.
00:05:57.420
And I have taken, over the years, various approaches, beginning with studies of human
00:06:05.700
adipose tissue aspirated using various needles from various subcutaneous depots in humans, meaning
00:06:13.960
around the rear end and in the front of the abdomen. And then became very interested in the
00:06:21.780
genetics of obesity and have done some studies trying to identify various genes that are related
00:06:28.680
to that and continue to do so. And have also done a large number of studies in mice designed to
00:06:35.560
look at this problem. And very recently, or at least within the past five or 10 years, have begun to focus
00:06:44.360
on the use of stem cells to try to understand, again, the biology of brain cells that regulate body weight
00:06:52.160
and the cells in the pancreas that produce insulin. Because obesity and diabetes go hand-in-hand
00:07:00.480
clinically. And this is not an accident. They're very tightly related in a number of really very
00:07:07.560
interesting ways. So that my studies of obesity have led more or less inexorably towards the study
00:07:16.560
of diabetes as well. So now my laboratory really does some of both. And you're at Columbia now. You
00:07:23.760
were at Rockefeller before that. But originally, you were in Boston, correct? That's correct. My clinical
00:07:29.300
training. I'm trained as a pediatrician and an endocrinologist. And that training took place
00:07:34.420
in Boston at both the Massachusetts General Hospital and the Children's Hospital. And then for
00:07:41.260
five or six years, I worked at both the Mass General and a community hospital in the Boston area,
00:07:48.600
the Cambridge City Hospital. Again, doing both general pediatrics and some endocrinology.
00:07:57.600
I was interested in obesity, or at least in the part of the brain that regulates body weight,
00:08:04.160
even as a medical student. We didn't study it specifically. It wasn't emphasized the role of
00:08:10.300
the hypothalamus, which turns out to be very important in that regard. But I had the opportunity
00:08:15.280
as a medical student, actually a first-year medical student, to work at the Walter Reed Army
00:08:21.880
Institute of Research with a neuroscientist named Harvey Carton, who was a physician who was interested
00:08:30.380
actually in the study of bird brains. And he took me on for a summer, actually it ended up being two
00:08:40.480
summers, to work in his laboratory, primarily helping with histological studies of the bird brain.
00:08:47.540
But the laboratory that he was in was run by a man named Wally J. H. Nauda, who was recognized at the
00:08:57.220
time, and subsequently perhaps even more so, as one of the great neuroanatomists with regard to the
00:09:03.880
hypothalamus. So actually I was indoctrinated a bit just by hanging around the other people who were
00:09:10.780
working there, including Dr. Carton, in terms of the importance of the hypothalamus in a number of
00:09:18.780
Where does the hypothalamus sit in relation to the pituitary, or even more grossly, like other main
00:09:25.260
Yeah, I think you can sort of picture it as lying between, or being triangulated in a sense, or at the
00:09:32.280
crosshairs of a line drawn between the eyes and the side of the forehead, and it's situated just
00:09:39.900
above the pituitary gland, if you know where that is.
00:09:43.500
Yeah, which is sort of behind the optic chiasm.
00:09:46.140
Yes, that's correct. And it's a very small organ, or at least it's a very small part of the brain,
00:09:53.640
about the tip of the small finger, but does play a role in the regulation of many important
00:10:00.640
physiological functions, including things like blood pressure, body temperature, and from my point of
00:10:09.200
view, very importantly, body weight, and also increasingly apparent that it plays an important
00:10:14.860
role in blood sugar control as well. So it's been known for many, many years as being a critical
00:10:21.700
part of the brain, a so-called vegetative brain, not under conscious control.
00:10:27.720
Work that's gone on over the past 30, 40, 50 years has increasingly raised the level of sophistication
00:10:37.260
with which we understand the function of that part of the brain.
00:10:42.240
About 21 years ago, or maybe 20 years ago, whenever it was, but early in medical school,
00:10:47.060
I remember when we did neuroanatomy, the professor said, if you have to sacrifice any part of your brain,
00:10:53.500
and you're sort of prioritizing, the last thing you want to sacrifice is the hypothalamus. If you're only
00:11:00.160
allowed to keep a couple square centimeters of brain, keep the hypothalamus.
00:11:05.220
You know, I mean, we could get into the weeds on exactly...
00:11:11.160
That's right. I think that would be important. The other thing you'd want to hang on to is the part of
00:11:15.900
the brain that regulates respiration. Because even with the hypothalamus, if you're not breathing,
00:11:24.840
I think he was excluding the brain stem for this.
00:11:27.100
I understand. I understand. I would... The hypothalamus is right up there.
00:11:30.280
Yeah. Yeah. At some point, I want to come back to it. I want to have you tell us all about Zucker
00:11:35.020
rats, because that's sort of what got me interested in this idea of how can this part of the brain,
00:11:40.980
when subjected to so many different types of insults and lesions, produce so many,
00:11:46.380
I mean, seemingly wild and disparate phenotypes that seem so out of whack. But before we go there,
00:11:52.800
let's go back to... You're a junior pediatrician schlepping along, taking care of overweight kids,
00:11:59.040
and we're in the, what, the late 70s? What time of year is this? What time of your life is this?
00:12:05.880
Mid-70s. So there's not that many obese kids, are there?
00:12:12.700
Okay. So what are you doing for them? How are you helping them?
00:12:15.840
So back in that day, the conventional view was that obesity was largely due to imbalances of
00:12:24.100
hormones, at least potentially, in addition to whatever other sort of behavioral issues might
00:12:29.360
be implicated. But almost all children with obesity were referred, if it was significant and severe
00:12:38.780
enough to either an endocrinologist or a psychiatrist. That was sort of the bifurcation point for referral
00:12:45.920
of these children. I don't think either the endocrinologist or the psychiatrist really could
00:12:51.320
do very much for these children. I certainly couldn't. And it was an evening in the fall in the city of
00:12:59.160
Cambridge in a small office that I used for the very small number of referrals that I actually saw.
00:13:06.220
Most of my time was spent with the medical students trying to teach them various aspects of pediatrics.
00:13:12.320
But one evening, I saw a young boy about seven or eight years old with his mother and examined him,
00:13:19.960
weighed him, and so forth, and determined. It's quite clear that he was very obese. He had no
00:13:24.760
other stigmata of the sorts of things that we looked for, meaning very severe problems with thyroid
00:13:31.880
or adrenal gland, which can sometimes produce severe obesity. And he didn't have any of the stigmata of the
00:13:38.080
single genetic type of disorders that were known about at the time, like Prader-Willi syndrome or
00:13:44.020
Part A. Beatle. And I said to the mother, your son has severe obesity. I can't tell you what the
00:13:52.560
etiology of it is. It's clear that there's something going on. There's problems that we don't really
00:13:59.340
fully understand or understand very well at all. And my only advice is to try to restrict the number of
00:14:07.140
calories that he eats and increase his physical activity, which is, I think, unobjectionable
00:14:13.660
advice in any circumstance like that. And the mother turned to the boy and said,
00:14:22.200
Randall, let's get out of here. This doctor doesn't know shit.
00:14:31.080
Oh, yes, I do remember his name. And she took him by the hand and they left. And I remember
00:14:36.880
sitting behind the desk and thinking to myself, Randall's mother, you've got a point.
00:14:44.240
And it was that experience, actually, I'd been interested in some of the physiological aspects
00:14:49.980
of obesity and adipose tissue that led me to decide that if I was going to do anything about
00:14:58.720
this, I was going to have to train myself to do the kind of research that might be helpful in terms
00:15:04.720
of understanding the disease. And it was shortly after that, that I actually moved to New York,
00:15:10.660
to the Rockefeller, to begin to try to do those kinds of experiments.
00:15:14.580
Yeah, that story, which obviously we've discussed before, and I get such a kick out of it. But at
00:15:20.660
the same time, it's actually a remarkable example of something that medicine is a privilege. It gives
00:15:25.840
you a privilege and it's up to you to do anything with it, right? Which is patients generally provide
00:15:31.020
the appropriate physician with the right level of humility. And I think, look, it's a testament to you
00:15:37.000
that you sort of could reflect on what Randall's mom said, because I think there are other people
00:15:41.560
who couldn't, right? There are other people who could say, well, screw you. That's the advice I've
00:15:45.160
got. And that's like the best I can do. And, you know, wouldn't skip a beat kind of moving on. But
00:15:50.320
when I talk to a lot of great physician scientists, that seems to be the one thing that they all have
00:15:54.980
in common. They may have many things in common, but this one is important, which is it's the ability
00:15:59.540
to sort of pause in your tracks and say, wait a minute, there is a clinical situation and I cannot
00:16:04.940
for the life of me explain it. And I have to know the answer. So it's so amazing that one
00:16:11.160
chance encounter like that basically altered the entire course of your career and put you on this
00:16:17.140
path to do some really amazing stuff as we'll, I think, discuss in the next hour or so.
00:16:23.580
I think you're probably right that one of the great, I think, privileges of a medical education
00:16:30.500
is that it does give you a very broad perspective on the human condition, if you want to call it that,
00:16:36.340
all the way from psychological issues to very fundamental biological ones. And physicians
00:16:43.460
as a group do have this, as you pointed out, rather unique opportunity to look at a problem
00:16:51.700
that afflicts human beings, sometimes at the level of basic metabolism and endocrinology,
00:16:59.320
other times on a more systemic or even social level. And I'm sure we could name some of the
00:17:06.720
names of people who have operated all these levels. But I think you're right. I've always felt that it
00:17:13.580
was really somehow an enormous opportunity and a gift to be able to pursue this down to the level
00:17:22.340
that I've been able to do in the past 30 years or so. And I must say, in addition to whatever my
00:17:29.780
previous training and experience did to make that possible, I also have to acknowledge that my family
00:17:38.020
was very supportive in terms of allowing me to basically back out of a more classical sort of
00:17:46.140
academic medical track and retrain myself to the level that I thought was required in order to do
00:17:53.840
this research or basically move from a very nice home in Brookline, Massachusetts to an 800 square foot
00:18:01.340
apartment in Manhattan with a wife and two small children and lived there for 15 or 16 years while I
00:18:11.340
sort of got my act together. There's plenty of great research that can happen at Harvard. Why did you
00:18:16.620
come to New York? I came to New York actually after looking around in the Boston area for someone who
00:18:22.940
could mentor me in this kind of activity. And it turned out there were, I mean, there's some interesting
00:18:28.780
stories about that. But the advice that I got from the people who were not in a position to help me in the
00:18:34.840
way that I thought I needed help was that I might consider going to the Rockefeller and working with a
00:18:40.420
physician scientist named Jules Hirsch, who at the time was very interested in the biology of adipose
00:18:47.160
tissue from a number of perspectives. And I had actually communicated with Dr. Hirsch in the literature
00:18:55.080
by commenting on some of the work that he had done with regard to adipocytes and signals that might come
00:19:02.840
from adipocytes that affect potentially food intake and body weight. This was an area that he was quite
00:19:08.840
interested in. And I was too, based on some of the thinking I had done about it while I was in the
00:19:15.080
training in Boston. And he and I actually had had a communication in the literature on some of the
00:19:21.360
work that he had done. And I went actually to visit his laboratory while I was in New York for an entirely
00:19:27.520
different reason. And it was very shortly after that that I moved. Which is another great example of
00:19:33.460
the types of common threads we see in great scientists, whether they be scientists or physician
00:19:38.880
scientists, which is mentorship, right? Again, every person I talk to who's done something remarkable in
00:19:44.140
science can point to mentors, a mentor or mentors. And obviously for you, Jules was probably the most
00:19:51.900
important mentor, I'm guessing. That's right. I had very important other mentors in the area of
00:19:58.060
clinical medicine. And the one who trained me in endocrinology, an individual, again, a physician
00:20:04.720
scientist, more clinically oriented named Jack Crawford, himself was very interested in the role
00:20:11.520
of body fat and its interaction with other physiological systems in the body, most notably the
00:20:19.400
onset of puberty. And it was he that actually put me in contact with another scientist at Harvard named
00:20:26.140
Rose Frisch, who also was very interested in why, for example, young women who lost weight as a result of
00:20:34.300
anorexia, or more commonly in her experience, due to very vigorous physical training for things like
00:20:42.040
distance running or bicycling, swimming, became amenorrheic. In other words, their period stopped. And Rose was
00:20:49.520
very curious about why this was and whether there was a communication between fat and parts of the
00:20:56.120
brain that regulate the gonadal axis, which is the hypothalamus again. And I remember having many
00:21:03.640
conversations with Rose about where the signal might be coming from. She thought it actually might be
00:21:09.360
coming from adipose tissue or adipocytes in the bone marrow. And it was always encouraging me to
00:21:14.940
study bone marrow as a source of whatever this signal might be.
00:21:23.460
At that point in time, was the adipose tissue, was adipose cell, was this regarded as an inert
00:21:33.240
sort of storage depot for fatty acid, or was it considered an endocrine organ? Like what was the
00:21:42.420
At that time, the view of the role of adipose tissue was very strongly in the direction of the
00:21:51.960
sort of former characterization that you made, which is that it was a passive depot for fat
00:21:58.200
in the form of storing free fatty acids as triglycerides so that they were hydrophobic,
00:22:05.980
so that you could pack a lot of calories into an organ or into a cell without having a lot of water
00:22:11.940
there. So it's a very efficient way of storing energy. Actually, as you know, up to probably around
00:22:18.740
nine calories per gram. And its role as a signaling device or an endocrine organ was really people
00:22:29.340
were thinking about it, but there was no firm evidence in this regard, other than I think the
00:22:36.740
increasing sense that the size of the adipose mass was doing something to the levels of circulating
00:22:44.620
insulin, that somehow insulin rises when the fat mass rises and the mechanism or the relationship
00:22:52.560
Not the other way around? Was it clear which direction?
00:22:55.700
So at the time, I think the view was pretty much that as fat mass increases, the concentration of
00:23:02.000
insulin rises to meet the consequences of so-called insulin resistance, which occurred not only in
00:23:10.280
adipose tissue, but maybe more importantly in liver and muscle, and so that there was some relationship
00:23:18.500
between fat mass and this endocrine. But fat mass is a secretory organ itself of molecules that might
00:23:27.620
have some of these effects. It was really a pretty new idea that nobody really had any direct,
00:23:37.140
Obviously, we're going to get to the story of leptin, which I think is just another great example
00:23:41.780
of incredible persistence, an incredible focus and drive. But obviously, before getting to the
00:23:49.200
punchline, which occurred several decades later, what was your first insight into a hormone that
00:23:57.140
would go on to be leptin? Where did you first figure this, that there was something that was being
00:24:01.600
secreted by fat cells? I think the first evidence in this regard, or at least some of the most important
00:24:09.700
evidence, came from experiments that were done by an investigator at the Jackson Laboratories in Maine
00:24:17.460
named Douglas Coleman. And Coleman was a biochemist, physiologist, who was interested in some of the rare
00:24:29.960
mouse mutations that led to very severe obesity. And he was one of the first to study
00:24:38.760
the OB-OB or obese mouse, which was a spontaneous mutation that arose in the Jackson colony.
00:24:48.360
And he also was one of the close students of another mutation that arose there a number of
00:24:54.840
years later in the so-called diabetes or DB gene.
00:25:05.640
That's not to be confused with the OB-1 Kenobi mouse. That's a very different phenotype, right?
00:25:10.440
The OB-OB mouse was noted to be very severely obese very early in life. So these animals were
00:25:21.900
clearly obese by the time shortly after weaning, which is three or four weeks of age. You could
00:25:30.560
tell that they were obese. And if you left them alone and let them eat as much as they wanted,
00:25:35.600
they would eat up to the point of becoming pretty heroically obese, meaning these animals could reach
00:25:43.320
weights of 70 or 80 grams. Whereas a normal so-called wild type mouse at maximum weight would
00:25:51.780
be somewhere around 40 or 50 grams much later in life. An OB mouse could get up to 60 or 70 grams
00:25:59.920
very early in life. The animals were infertile.
00:26:03.400
So how did you, how did they keep breeding them?
00:26:05.380
So the way they would breed these animals is breed the parents, the heterozygous animals that were able
00:26:18.940
It's centered around two phenotypes actually that Dr. Coleman was able to show. Primarily the
00:26:25.600
obesity was due to hyperphagia, but he also was able to demonstrate by a mechanism.
00:26:30.600
Sorry, I should just clarify for listeners. That means excessive appetite.
00:26:34.380
Yes, by excess food intake. That was the primary cause of their obesity. But he also,
00:26:41.140
by using a technique called pair feeding, where he would only feed the animal the amount that a
00:26:46.000
normal weight animal would eat, that those animals tended to store more of their excess calories as
00:26:52.260
fat. We sometimes refer to this as partitioning. And by another set of experimental maneuvers was
00:26:58.860
able to show that their metabolic rate was slower. So these animals had what you might call a trifecta
00:27:05.860
for obesity. They ate more, spent less, and whatever they stored was preferentially stored as fat.
00:27:14.180
And these were fascinating animals. I mean, people tried for many years to figure out what was wrong
00:27:20.140
with them. And they had many metabolic consequences of their obesity, but nothing about their physiology
00:27:27.020
necessarily pointed to what the primary mechanism was, where the genetics clearly indicated that this
00:27:35.840
was a single gene, or very likely to be a single.
00:27:39.300
And this, of course, is long before you've got your PCR technology that can very easily help you
00:27:45.380
sequence this. So two questions, though. Lifespan was what?
00:27:49.560
Lifespan, not severely affected, actually. They could live to a fairly normal lifespan,
00:27:58.060
Not quite. They don't last quite that long, but certainly up to 18 months or two years.
00:28:03.620
Important to note, because of the question of whether fat makes something or not, Coleman
00:28:08.440
not only observed these OB mice, but also this second mutation that arose later at the Jackson Lab and was
00:28:17.180
named the diabetes mouse. That's because that animal looked a lot like an OB mouse, but got diabetes
00:28:24.240
very early in life, unlike the OB mouse, which seemed to be obese, but not necessarily particularly
00:28:32.880
diabetes prone. And it was clear that the mutation in the gene, again, another single gene that caused
00:28:39.800
the diabetes mouse, was not the OB gene. It was on a different chromosome. Coleman was able to show
00:28:46.680
that. So here you had animals that looked a great deal like each other, at least in terms of the
00:28:53.600
overeating and the low energy expenditure. One was prone to get diabetes and the other not. And what
00:29:00.180
Coleman ultimately did was to join the circulation of the OB mouse to a wild-type animal and the DB or
00:29:11.280
diabetes mouse to a wild-type animal. So like a live parabiosis. It's a lot. That's the technical
00:29:17.220
term for it is a parabiosis. And he showed that if you hooked an OB mouse up to a wild-type mouse in
00:29:24.080
this way, that the OB mouse would correct its hyperphagia, its excess food intake, and actually
00:29:32.240
begin to lose weight. So something presumably in the wild-type mouse, some humoral factor, some hormone,
00:29:38.920
some something, must have been missing in the OB-OB mouse that, when given to it, corrected its
00:29:45.660
phenotype. Correct. And then what happened when you did the parabiosis with the DB mouse? With the DB
00:29:51.000
mouse, you got the opposite situation, where the wild-type animal began to lose weight and actually
00:29:59.600
stopped eating and would die of starvation, basically. Whereas the DB mouse just went merrily on its way,
00:30:06.480
eating and remaining obese. So Coleman thought, based on these two experiments, that maybe the OB mouse
00:30:17.300
was missing something that the wild-type mouse produced, and the DB mouse, that looked an awful
00:30:22.780
lot like an OB mouse, was missing the ability to respond to whatever that molecule or molecules
00:30:30.320
were that were required to regulate body weight. And this was around the time that it was becoming
00:30:36.900
clear that hormones had receptors that were specific to those hormones, like thyroid, insulin,
00:30:43.220
growth hormone. So Coleman hypothesized that the OB mouse was missing what we refer to as the ligand,
00:30:50.780
the circulating hormone, and the DB mouse was missing the receptor for it. And it turns out
00:30:57.680
that Dr. Coleman was right. Everything you've just said was known by what point in time?
00:31:03.640
I would say by the late 1970s. Okay, so just as you're coming on the scene, the whippersnapper who
00:31:10.020
doesn't know shit. Yes. The guy up in Jackson, up in Maine, knows this, and you can't wait to get all over
00:31:17.680
this. Correct. So I began by actually studying adipose tissue to see whether there was something
00:31:26.240
that might be regulated by adipose tissue that would fit in this sort of general category of
00:31:33.960
something that might produce a signal or might be related to the anatomy of the adipose tissue.
00:31:41.880
At the time, Jules Hirsch was particularly interested in the fact that it appeared that what happens when
00:31:48.720
people get obese is that their fat cells expand up to a sort of maximum size, and then new fat cells
00:31:55.900
begin to appear. Whether they were made de novo or had been resting in the area of the other adipocytes
00:32:02.180
wasn't clear at the time. But what happens as people get more and more obese is that more and more fat
00:32:08.060
cells are recruited so that if you look at a very obese individual, they have what is referred to in
00:32:15.300
the literature as hyperplastic adipose tissue. They have more fat cells. And Jules had actually figured
00:32:20.620
out a way to count the fat cells of a human being. And you can look under a microscope and see how big
00:32:27.140
the fat cells are. So he was very interested in what it is that permits a big fat cell to call up,
00:32:35.060
if you will, the other fat cells that are going to be needed once it reaches a critical size,
00:32:40.660
and whether these fat cells were generating something that might act like a signal.
00:32:46.180
Are there any organelles inside a fat cell? Oh, yeah. Fat cell has the complete repertoire
00:32:50.820
of organelles that any other cell does. So it's got a quote-unquote regular nucleus. It's got
00:32:57.260
mitochondria. Oh, yeah. Yeah. It's got the whole... It's just its cytoplasm is dominated by these lipid
00:33:03.460
droplets. Correct. It's designed to be able to hold these huge lipid droplets, but otherwise is a
00:33:08.640
perfectly respectable cell. It has all the other components. And what Jules had been doing, along
00:33:17.200
with another investigator in the lab, a guy named Irv Faust, was extirpating adipose tissue from rats.
00:33:24.640
They were working primarily with rats, although there were some OB mice around. I'd actually seen
00:33:30.500
those when I was at Harvard in Boston. An endocrinologist who trained me used to talk to me
00:33:35.880
about them. But Jules and Irv were extirpating adipose tissue depots from rats and looking to
00:33:44.640
see what happened. And one of the things that they were struck by is that when they took a fat pad out,
00:33:50.560
if they waited long enough and just let the animal eat whatever it wanted to eat, it would eat its way
00:33:56.780
back up to restoring that fat pad. Through de novo creation of more fat cells?
00:34:02.280
So you leave the capsule of the depot there and it is able to regenerate new fat cells and they fill
00:34:11.100
up and they don't fill up to three times the size that they were before. They go right back to the
00:34:16.360
appropriate size for that depot. And one of the things that Jules and Irv were very interested in
00:34:24.360
is how does the animal know that it should eat a little bit more to be able to generate the fat
00:34:32.040
that's been extirpated? And did this experiment only work when you started with obese rats or did
00:34:38.580
it work if you took a lean rat as well? It worked with lean rats just as well. As a matter of fact,
00:34:44.040
most of the work they did was with lean rats or not genetically obese rats.
00:34:49.120
Now speaking of rats, you explained to us what the OB-OB and the DB-DB-DB-OB.
00:34:56.860
What about the Zucker rat, which preceded a lot of this stuff but had some interesting and similar
00:35:01.040
features, right? Right. So the Zucker rat was discovered or identified, if you will, by a woman
00:35:08.520
named Lois Zucker, the rats named after her and her husband. And it had characteristics very similar to
00:35:15.280
these mice that we were talking about, the OB and the DB mice. They were hyperphagic. They
00:35:21.520
appeared to have a little bit lower energy expenditure and would become hugely obese. I
00:35:28.260
mean, these animals got up to heroic size. Yeah, we're going to include some pictures of the
00:35:33.520
Zucker mice in this, in the notes. The Zucker rats.
00:35:37.760
Got very, again, got very obese. And many, many studies were done of the Zucker rat trying to,
00:35:45.320
again, understand what the mechanism behind its obesity was. Again, it appeared to be due to a
00:35:53.400
single gene. In other words, like the OB or DB mouse, there was a single mutant gene. When the animal
00:35:59.320
had two copies of the abnormal or low activity gene, the animals would become very obese.
00:36:05.940
And one of the reigning hypotheses about the Zucker rat, again, at around the late 70s, early 80s,
00:36:15.540
was that the fat itself was making too much of an enzyme called lipoprotein lipase. And this is an
00:36:24.680
enzyme which is produced by adipose tissue, by adipocytes, which breaks down circulating triglycerides
00:36:32.500
and allows the free fatty acids that are released to be taken up by the adipocytes. And the glycerol
00:36:40.280
backbone, so to speak, remains in the circulation. So the idea was that the Zucker rat, for some reason,
00:36:46.980
had hyperactive lipoprotein lipase. And the adipose tissue was acting like a vacuum cleaner,
00:36:53.820
in a sense. It was sucking up the circulating fat, the triglyceride, and storing it. And that's how
00:37:01.900
the animals got obese. And in association with that observation was the idea that maybe the process of
00:37:09.100
sucking up substrate from the circulation does something to drive or increase food intake. So
00:37:18.120
this model was often referred to as a pull model for the development of obesity. That is that the
00:37:26.260
adipose tissue was actually acting as a pulling mechanism for substrate, which was in turn affecting
00:37:33.280
food intake. So the animal got fat that way. So the animal was effectively starving. Even though it
00:37:39.340
stored an unbelievable amount of energy, it was disproportionately taking those circulating
00:37:45.280
metabolic fuels and putting them into storage. So that if you buy this idea that something is
00:37:51.520
sensing energy availability, that would naturally drive the hyperphagia, right? Correct. And the other
00:37:58.240
model, the one more consistent, say, with the OB or the DB mouse, was the so-called push model,
00:38:05.340
which is that fat cells were being filled up because the brain itself had a... Was pushing.
00:38:11.140
Pushing the substrate. So these push-pull models were very much discussed in terms of what they said
00:38:19.720
about where the primary mechanisms might be for the control of body weight. Was it the adipose tissue
00:38:27.380
that was basically begging for more fuel and sucking it in and causing the animal to eat that way? Or was
00:38:33.920
there something going on primarily in the brain that was influencing the food intake and the
00:38:40.880
adipose tissue was being packed from the outside? And like all good problems in medicine,
00:38:46.060
there's examples of both that are quite elegant, right? I mean, that's sort of the challenge of
00:38:51.340
this is when you look at this in experimental models, you could find very elegant examples of
00:38:57.080
each, correct? You could find elegant examples that pointed in the direction of both of these.
00:39:03.320
It was interesting. I mean, it was the whole issue of lipoprotein lipase suggested that,
00:39:09.380
again, this model, the Zuckerrat, it was used to support this idea that the LPL was, as it was
00:39:15.980
referred to, was critical in this regard. But it was known that individuals who had total lipoprotein
00:39:23.380
lipase deficiency, and there are such individuals on a genetic basis, had very, very high levels of
00:39:30.460
circulating triglyceride. I mean, these can be life-threatening in terms of the levels that are
00:39:35.620
reached, but they had perfectly normal adipose tissue. So this suggested that maybe LPL wasn't
00:39:41.540
critical or absolutely necessary. Meaning you would expect those patients to have sky-high
00:39:46.680
triglycerides and be emaciated. Yes. And they weren't. And they aren't. So this was already sort
00:39:53.060
of a question about the lipoprotein lipase. And we know that those patients were completely
00:39:58.640
deficient in LPL? Yes. Does that mean they had no LPL on their muscle cells as well?
00:40:03.140
So the individuals who are totally deficient in LPL have no LPL on any cell type.
00:40:11.960
It's hard to imagine how they function. Does that mean they're completely dependent on glycolysis?
00:40:17.000
They are able to take up the fatty acids. They don't need the LPL to break down the triglyceride.
00:40:23.800
They do fine. I mean, in terms of being able to, there's nothing wrong with their manipulation or
00:40:28.840
movement of fatty acid. And that's probably why they have normal adipose tissue and normal muscle.
00:40:35.800
So it's interesting, the history of this, and just to mention this, we now know what the Zucker
00:40:42.560
mutation is. And one of the earliest experiments I did at Rockefeller, or one of the relatively early
00:40:49.480
experiments, is we tried to map the position of the Zucker obesity gene in the same way that we
00:40:58.360
were already trying to map where and ultimately clone the OB and DB gene for pretty obvious reasons
00:41:05.300
at this point, that we wanted to figure out what the signal and whether there was a receptor for this.
00:41:11.800
And as part of this work, a student who worked with me named Gary Truitt made a map of the position
00:41:19.480
of the Zucker gene, which we did by crossing the Zucker rats with another strain of rats so that we
00:41:25.760
could make what's referred to as a genetic map. And tell me how that works, because everything I've
00:41:30.960
ever done with genes came after we had the luxury of real-time PCR. And we just said, you know,
00:41:37.380
my generation had it so easy. You guys, like, when I hear stories about people doing positional gene
00:41:44.200
stuff, you know, 40, 50 years ago, I'm like, wow, that's incredible. So tell me a little technically,
00:41:50.780
like, what were you actually doing to positionally isolate that?
00:41:54.960
So the way these experiments are done, it's pretty much the same principle, is that you take,
00:42:01.480
in the case of rats or mice, which you have this luxury, you can cross one strain of,
00:42:07.380
mouse or rat, to another strain of mouse or rat, and then look for signposts of genetic variation
00:42:16.000
along the entire genome of the animal. And each strain has different sequences of DNA.
00:42:26.040
Major differences are in the so-called non-coding region. Some of the differences are in coding
00:42:31.840
regions. And back then, we used a technique called southern blotting to look for
00:42:37.080
basically putting down signposts on the DNA of an animal to figure out where the differences between
00:42:44.800
the strains resided. And by monitoring the obesity of the animal and knowing which strain was actually
00:42:54.420
carrying the gene that we didn't know what it was, but we know what strain it came from,
00:42:59.440
in this case the Zucker strain. We could actually mark the DNA of these animals that had been
00:43:06.880
interbred and figure out where the Zucker chromosome, the Zucker genetic markers, were segregating,
00:43:16.940
is the formal term for this, along with the level of obesity of the animal. So we would look for
00:43:22.160
correlation of region which has the Zucker genetic variation with the obesity of the animals. Because
00:43:31.280
if you do these crosses in the way that I described, you get some obese, you're going to get in some
00:43:36.840
non-obese animals. And then by relating where the sequences are corresponding to the strain from
00:43:44.520
which you know the obesity gene must have come, you can actually narrow the region of the genome down
00:43:51.080
to the area that must contain the gene. I mean...
00:43:54.520
And this was a qualitative assessment, not so much a quantitative assessment, right?
00:43:58.680
So the quantitative assessment is, is the animal obese or not obese? You absolutely have to get this
00:44:05.840
right because you're, the obese animal has, in this particular model, two copies of the mutant gene
00:44:12.720
that's producing the obesity. And if it's not obese, it either has one or zero copies. And you need to be
00:44:18.880
absolutely clear what the phenotype is, so to speak, of the animal is. And then if you put these markers
00:44:27.360
down, these signposts down, you can define them, an interval in which that gene must reside. So it's
00:44:37.080
actually, it's, it's in a sense, it's quantitative at the level of the phenotype.
00:44:42.540
So the best you could do is say this is on, you know, 17P or 17Q. That's, that's like the level of
00:44:51.560
What happened when they did a parabiosis with a Zucker rat? Did anyone do that?
00:44:55.180
There have been parabiosis experiments done with rats, but they've generally done these in a,
00:45:03.600
in a slightly different way from the way you asked the question. And those studies have again,
00:45:11.860
supported the idea that the Zucker rat may be overproducing, like the DB mouse, the product,
00:45:19.100
which is suppressive of food intake. And as a matter of fact, when we were trying to clone
00:45:25.120
these genes, I actually took blood out of Zucker rats and injected it into DB mice to see whether
00:45:33.280
or not I could slow down their food intake. Because at one time we were worried that we might not be
00:45:38.400
able to get the gene by mapping and would have to try to isolate the product out of the blood of an
00:45:43.300
animal. But the Zucker rat studies supported the idea that the same as the mice.
00:45:49.560
So we'll fast forward now into the late seventies, early eighties. You're working mostly now in the
00:45:55.800
lab. Your clinical responsibilities have shrunk significantly, right?
00:45:59.660
So at the time I was doing these experiments, I had some experiments still going on, no clinical
00:46:07.240
practice at all. But I was studying humans in the clinical research center at Rockefeller,
00:46:13.220
looking at the effects of weight loss and weight gain on energy metabolism in these individuals.
00:46:23.440
Again, beginning to try to understand what it is that's regulating body weight in a human. The idea
00:46:30.800
being that if you reduce the body weight of a human down by 10 or 20%, what happens to them
00:46:38.020
metabolically that might be consistent with some of these things that had been seen in mice,
00:46:44.260
that would suggest that again, in humans, there's regulatory pathways that are there in order to
00:46:52.340
regulate the amount of stored energy. So my time was basically split between doing these studies of
00:46:59.940
humans who were in the clinical research center for long periods of time, when we would study the
00:47:04.820
metabolic consequences of perturbing their body weight. The other was spent trying to identify
00:47:11.300
these genes or try to clone the genes. So how did that progress through the eighties as you were
00:47:18.180
working to try to identify specifically the OB OB gene? And again, the reason you were pretty confident
00:47:25.140
that it was a single gene was just based on the breeding pattern? Yes. The breeding pattern clearly
00:47:30.580
indicated that this was a single. Because it was sort of Mendelian. Yes, absolutely Mendelian.
00:47:35.940
It's a so-called autosomal recessive Mendelian, as is the DB mouse and the Zucker rat. So what we did
00:47:43.060
is what I basically described for the rats. Why was it harder for the mice? To clone the gene? Yes.
00:47:49.780
It was not harder. No, no. I think it was equally difficult. What I was describing is when we didn't
00:47:56.420
actually sort of finish that part of the conversation. We did make a map of where the
00:48:02.340
Zucker gene was located in the rat. But we didn't clone the gene out of the rat at that time. And
00:48:10.020
what that experiment showed is that that was interesting apropos this lipoprotein lipase
00:48:15.620
hypothesis is that the Zucker gene was in a part of the rat genome entirely separate from where the LPL
00:48:24.740
LPL gene was located. So from that experiment alone, we knew that it couldn't be LPL as the
00:48:34.660
causal mechanism of the Zucker rat. We didn't know what it was, but we could clearly identify what it
00:48:42.660
wasn't. Because if the gene is not in the location that is segregating with the phenotype, it's not the
00:48:51.060
gene. This was hard for people, I think, to understand or at least to accept at the time.
00:48:57.700
There still, I think, was not full appreciation of what an experiment like that represents,
00:49:05.300
which is basically an unequivocal falsifying experiment. That is, if it isn't in the place
00:49:12.180
where the gene must be, then it can't be the gene. I mean, it's a syllogism.
00:49:17.460
Yeah. And you don't get a lot of those in science.
00:49:22.340
Right. And so this early on, this was one of the proofs that at least we knew one gene
00:49:29.460
And then to sort of back then to your question, we used a very similar strategy,
00:49:35.140
an identical strategy with the mice. We crossed the mice to strains that were different from the
00:49:41.140
strain on which the mutation existed. And by doing that, we're able to make maps
00:49:45.620
of the region where the gene was located. And I was actually known for other reasons. Coleman
00:49:52.260
had figured it out. He knew which chromosome these genes were on. So we at least had that
00:50:00.260
as a sort of initial guide. But what the gene was or how it worked was obviously entirely unknown.
00:50:10.980
Coleman was trained as a biochemist at the University of Wisconsin, I think. And we actually
00:50:16.100
consulted with Dr. Coleman, Doug, very early on, as a matter of fact, very early on in the process,
00:50:22.020
about which strains of mice might be appropriate as so-called counter strains. That is,
00:50:27.380
mice that would be used to enable these maps to be made. And he was extremely helpful. I mean,
00:50:35.540
we used to come down, we would talk to him, go visit him at Jackson on at least one occasion,
00:50:45.540
He loved it. It was very encouraging. He always said that he wasn't sort of au courant with regard
00:50:53.300
to the tools of so-called molecular genetics. But in fact, I and Jeff Friedman, who was the
00:50:59.380
other sort of PI on this project, neither of us was expert in molecular genetics.
00:51:04.740
So we sort of had to train ourselves to do this, as did the students who worked with us on this project.
00:51:13.300
I got to know Jeff because he rotated as a resident, actually, at New York Hospital through
00:51:22.020
Jules' lab to work with another investigator there. So I got to know him when he rotated through.
00:51:28.260
But he and I started this project after he entered the Ph.D. program. He was a physician and then went
00:51:36.100
on to get a Ph.D. at Rockefeller in a different laboratory. But he and I started the project to
00:51:45.700
1985 or six, I guess. And, you know, 86, probably.
00:51:51.380
What were the major steps that took place starting around the mid-'80s that were kind of like the
00:51:57.940
essential? I mean, I think one of the things that's just hard for people, I think, to understand is
00:52:03.060
how much you have to fail in science. I mean, it sounds simple, right? We want to clone a gene.
00:52:09.940
And yet, in that era, that was very hard to do.
00:52:14.820
Right. There were efforts underway at around the same time to clone the gene for Huntington's disease
00:52:22.100
and cystic fibrosis, muscular dystrophy, to name a few.
00:52:28.340
Other single gene disorders. And for a number of reasons, genes that are on
00:52:33.940
sex chromosomes may be a little bit easier to handle in this regard. But the same tools were being used,
00:52:41.700
the so-called southern blotting, putting down markers across the genome, using this rather
00:52:46.580
tedious technique of having to put the DNA down on a blot of some kind and then exposing it with
00:52:54.420
radioactively tagged reagents to be able to find these individual markers. This was a
00:53:00.980
tedious process. One thing that helped with the mice is that there existed a chromosome
00:53:06.740
in mice. So these are called Robertsonian chromosomes in which you have two chromosomes
00:53:12.820
joined to each other. And there was a so-called Robertsonian chromosome that had both chromosome
00:53:18.260
4 and chromosome 6 of the mouse attached to each other. We knew based on Doug Coleman's work that
00:53:25.780
the OB gene was on chromosome 6 and the DB gene was on chromosome 4. And one of the students who came
00:53:32.740
to work on this project very early, a young man named Nate Bahari who came over from New York hospital
00:53:40.500
as a medical student and spent time on this project and then went on to get a PhD working on it, he took
00:53:47.860
glass needles, if you can believe this, and dissected out under a microscope the rough regions of the
00:53:56.100
chromosome 6 and 4 that we knew must have the gene in them and made from those needle dissected
00:54:05.060
chromosome fragments other markers that we could put down on the DNA from these mice that we had
00:54:13.460
intercrossed to make a finer and finer map of the region in which the gene must reside. And otherwise this was
00:54:21.700
identical to the Zucker strategy in which we very carefully looked at see whether a mouse was obese
00:54:29.300
or not, and again these are mentalizing phenotypes, but we had to be absolutely sure what the phenotype
00:54:36.340
of the mouse was and then we could use the DNA from the obese animal to make a finer and finer map around the
00:54:45.780
region where the gene must reside. I don't even understand how that would work. What resolution of a
00:54:50.180
microscope would you need to be tweaking chromosomes? Chromosomes aren't that small. I mean you can see
00:54:55.540
a chromosome quite easily with a high-powered just a light microscope. Yeah, light microscope. But
00:55:01.300
having the steady hands to be able to and the patience to be able to do this was quite an achievement.
00:55:08.420
I would say it was sine qua non without which this project wouldn't have been done at the time. We didn't
00:55:15.380
have the tools, some of the ones that you already mentioned, available. So we had to try to identify
00:55:21.540
additional signposts, if you will, in the region of the two genes that we were primarily interested in,
00:55:29.380
that is the OB and the DB gene. At the time you're basically thinking,
00:55:32.740
look, we're looking for a gene for a hormone, we're probably looking for a gene for a receptor,
00:55:36.660
so a ligand receptor. Did you have an expectation that those would be on the same chromosome or would
00:55:40.900
that be completely unnecessary? No, we knew that they absolutely weren't. No, no, I knew you knew
00:55:45.380
that they weren't, but would you expect that? No. For example, like in thyroid, is T4 and TSH or T4 and
00:55:54.980
TR, like you know the thyroid receptor, TSH and TSR, are they necessarily? No. No. There's no
00:56:01.220
relationship. No. Yeah. No. So the function doesn't require that the genes be in proximity to each other,
00:56:07.140
and if they are, it's almost always just a coincidence. Got it. So what was the kind of
00:56:13.300
critical breakthrough that led to the cloning of this gene? So what was done basically was to make
00:56:22.660
the map as fine as we could using the reagents that I mentioned to you and some others that we were able
00:56:29.620
to get hold of and using computer programs to put these data together in such a way as to be able to
00:56:37.780
generate as fine a map of the region around this gene as we could. And then what was done was to go
00:56:45.460
into the region that must contain the gene and begin to look for expressed, meaning that the DNA was
00:56:55.300
transcribed transcripts that were being read off of this part of the DNA. And by taking the transcripts
00:57:04.740
that came off and putting them against various organs from the OB or the DB mouse, we would look for
00:57:14.740
transcripts that were specifically altered in the animals that were mutant for the gene. So you would
00:57:23.220
expect, you might ordinarily expect maybe the level of the gene that we were looking for would be very low
00:57:29.300
in the organ that was affected. And again, even though we know now it was adipose tissue and there
00:57:35.380
were certainly reasons to think that might be where the OB gene was, when we did these experiments we
00:57:40.900
actually looked at every organ in the animal, brain, thyroid, muscle, adipose tissue, anything we could
00:57:48.580
get our hands on. We actually dissected out almost everything out of a mouse to look to see where the
00:57:56.180
deficiency or the excess might be. Sometimes gene transcripts are overexpressed, although they're not
00:58:02.500
functionally competent. And actually at a visit to the Jackson labs when Doug Coleman was retiring,
00:58:11.460
one of the investigators there asked me if I would like to have, or we would like to have
00:58:18.740
mice that appeared to have the OB mutation, but a different mouse. So the original mutation occurred
00:58:26.340
in the mouse that was identified at Jackson in the early 1950s. This was a new mutation that had arisen
00:58:33.380
and almost certainly wouldn't be identical to the one that had arisen earlier.
00:58:37.540
But it was similar in phenotypes? Absolutely identical in phenotypes. So I got those mice
00:58:43.220
and we took them to Rockefeller. What did you call them?
00:58:47.380
2Js. So the OB, the first mutation we referred to as 1J, that's just the nomenclature. And the
00:58:54.420
second one was OB 2J. And we took the OB organs out of the 1Js and the 2Js and ran these transcripts
00:59:03.700
against them using the technique called Northern blotting at the time.
00:59:09.540
Not to be confused with Western blotting. So Northern blotting is looking actually at RNA.
00:59:14.340
It turned out that the 2J was extremely valuable animal because those animals didn't express any
00:59:23.380
of what turned out to be the leptin transcript. Whereas the 1Js actually overexpressed it,
00:59:31.700
but it was functionally inadequate, functionally inactive. But the transcript was increased,
00:59:38.260
again, for reasons having to do with the molecular biology of how these systems work. But when we saw
00:59:43.780
that there was one animal that had a very low level and the other very high, this was a smoking gun,
00:59:50.740
so to speak. This was the evidence that that piece of the genome was actually a part of the OB gene.
00:59:58.340
So ultimately, where did this ligand, where did it show up?
01:00:03.380
The OB gene showed up almost solely, virtually solely, I mean, in adipose tissue. Fully consistent
01:00:11.140
with the idea that adipose tissue was producing something that was picked up in Doug's parabiosis experiments.
01:00:20.660
Chromosome 6 of the mouse, it's chromosome 7 of the human. We actually knew that because we could put the
01:00:30.100
orthologs of the mouse genes down on human DNA. And so just like we did with the Zucker rat,
01:00:50.580
I mean, it's referred to as the OB gene or the name that was given to the protein is leptin,
01:00:57.060
which was, the name was chosen because that suggested that whatever this was,
01:01:02.980
it had an effect to lighten the body weight of an animal.
01:01:06.580
So now you have it that the fat cell secretes leptin and the OB mouse can't make leptin, correct?
01:01:17.460
And the DB mouse makes all the leptin in the world.
01:01:20.260
This wasn't known at the time because the gene, the first gene to be cloned was the OB gene.
01:01:27.140
And the fact that the DB gene was the receptor was actually learned in two ways.
01:01:34.260
One by taking the OB protein and putting it down on what's called an expression library
01:01:44.580
Wait, sorry, to interrupt one thing, Rudy, I apologize.
01:01:47.620
Did they ever do parabiosis between the OB and the DB?
01:01:59.300
Which is another great and elegant example that one of them had the ligand deficiency,
01:02:05.940
God, Mendelian genetics are freaking awesome when they work.
01:02:09.540
Well, so that was one of the reasons for using these animals is that you could use the genetics
01:02:14.020
to really help to narrow down the region where these genes had to be located.
01:02:19.220
If it were a polygenic disturbance, it's really, it's a whole different order of business.
01:02:24.020
So basically the DB gene was, or the protein that was nominated to be the DB gene was pulled
01:02:31.860
out of a library of what's called an expression library of choroid plexus by using the OB protein
01:02:42.020
And that gene that was pulled out of the choroid plexus in that way, we then took and mapped
01:02:51.860
into the DB crosses that we had and showed that that, if you will, nominated gene mapped
01:03:06.100
Correct. And it also turned out that that gene, the DB gene, the leptin receptor, is the mutant
01:03:14.020
in the Zucker rat, which we showed by cloning the gene then out of the Zucker rat, knowing where it was.
01:03:21.700
So this was hailed as one of the most important insights and breakthroughs in all of obesity
01:03:35.460
What was your expectation at the time? What type of hope did you hold out for
01:03:40.020
the discovery of the gene, but perhaps more importantly, the protein that it coded for?
01:03:45.620
So there were different schools of thought with regard to what this protein actually did. I think
01:03:51.860
one view was that if you saw this as a protein that suppresses food intake, which it definitely
01:03:59.940
does in an OB mouse. If you give it to an OB mouse, you can basically, quote, cure the animal.
01:04:06.980
And if you give it in very high doses to a mouse, it will suppress its food intake.
01:04:12.340
So one view was that this was a weight suppressing hormone. The other view, which was taken by
01:04:21.620
Jeff Flyer, who was at Harvard at the time, later became dean, still at Harvard.
01:04:28.020
Streamson Chua, who was working on this project or had worked on it, and myself, was that the
01:04:34.660
protein was actually more important in its deficiency state as a signal to the brain that you didn't have
01:04:42.020
enough energy to survive under circumstances of a fast or to have enough energy on board to successfully
01:04:48.660
complete a pregnancy. So one view was that very high levels would normally suppress body weight,
01:04:55.300
although it was hard to imagine at the time. Evolutionarily, that was not a natural state.
01:04:59.620
That's correct. So that's why we were wondering right from the beginning, why would nature invent
01:05:04.340
something that would... Right. It makes more sense that nature would say, here's a hormone that if
01:05:08.820
it's low, is a kick in the pants to eat. That's correct. Or, and maybe other things, right? Maybe
01:05:13.860
prevent you from getting pregnant. Yes. And that's, I think, turned out to be the correct model for how
01:05:19.220
this hormone, its primary mechanism of action is that it is there to tell the brain that you don't have
01:05:26.180
enough fat. And in an OB mouse, you don't make the hormone leptin, so the brain thinks you don't have
01:05:32.500
any fat. And in the DB mouse, it doesn't receive the signal from the perfectly adequate amounts,
01:05:39.220
actually high levels of leptin, so that the animal again thinks that it's starving.
01:05:44.740
Are there human conditions that mimic the OB and DB condition of the mice?
01:05:49.460
Yes. So there are humans. There are a handful of humans who have mutations of the OB gene and are obese
01:05:56.020
and have many of the phenotypic characteristics of a... And these are patients that you've cured with
01:06:01.700
this by giving... You give these patients leptin and you cure them.
01:06:04.100
Yes. They're curable by giving leptin. And there are a handful, again, of individuals with leptin
01:06:10.260
receptor mutations, which are comparable. How do you help those patients?
01:06:14.900
Those... The leptin won't help. You can't treat them with leptin. And there is no effective intervention
01:06:21.380
for those people at this time, although there are drugs that are being developed that are designed to
01:06:27.460
act downstream of some of the actions of leptin that might, if you could, rectify the activity
01:06:34.580
there. For example, at a receptor called the melanocortin-4 receptor, that would presumably
01:06:41.460
or possibly help to rectify the phenotype of those individuals. Although at present,
01:06:46.340
it's not a proven effective intervention. It might turn out to be.
01:06:50.180
I mean... It wasn't long after the discovery of leptin that... What drug company came in?
01:06:56.660
Amgen. So Amgen obviously bought the rights to do this, thinking this could be a blockbuster obesity
01:07:03.380
drug. It turned out not to be because unless you had a leptin deficiency, it didn't seem to help much,
01:07:09.620
Correct. There was a major trial of the use of leptin as a therapeutic agent in obese individuals,
01:07:16.900
and neither the obese individuals or the lean individuals who were in the study as controls,
01:07:23.060
responded very much to raising blood levels as much as tenfold above where they were normally
01:07:31.220
located in those individuals. So I just did a blood draw. I've been doing a blood draw on myself
01:07:35.620
every seven days because I'm doing... You know me, Rudy. That's just the shit I do. So my leptin level
01:07:40.820
last Friday was two or less than two. The cutoff was two. So I have a low level of leptin. So if you
01:07:49.140
gave me enough leptin to raise my serum levels to levels that I rarely see clinically, like when I
01:07:55.220
check leptin levels on patients, which I always do, I always want to see leptin. I want to see
01:07:58.740
adiponectin. I want to see insulin. I want to see NIFA, FFA, etc. It's very unusual that I'll see a
01:08:05.540
leptin level, even in an overweight patient, more than about 40 or 50. So if you took me and you gave
01:08:12.020
me that much leptin, do you think it would regulate or depress my appetite in any way?
01:08:17.300
Well, first of all, your leptin is low now because you're not eating. So...
01:08:22.180
Oh, this is even... This is back when I was eating too.
01:08:24.260
Right. So leptin is very highly correlated with body fat. At any level of body fat, if you stop eating,
01:08:31.220
if you restrict calories, the level of leptin will drop by...
01:08:39.060
So if we check a leptin level on a patient in the morning following a 12-hour fast,
01:08:43.300
we can assume that that's about half what they're fed leptin level is?
01:08:46.660
Well, 12, it depends on what they've been eating. 12 may be a little short in that context. So
01:08:54.620
But it'll start down within 12 hours. So a 12-hour fast will give you a leptin level,
01:08:59.180
which is not what it would be if you were to draw it when the patient is...
01:09:02.700
So let's say my fed level is 2 or 3 or 4. My fasting level is less than 2. If you injected
01:09:10.700
me with enough leptin such that, let's just say my level was now 100, the level that you would see
01:09:15.740
in the highest fed obese patient, what would that do to me?
01:09:20.060
Based on the studies that have been done, the so-called leptin trial, not very much.
01:09:26.780
You might have some, at least in some of these individuals, there was some reduction in body
01:09:38.140
Yeah, primarily, apparently, yes. Although there weren't detailed formal studies of food
01:09:49.660
Now, going back to the DBs, who obviously have, in many ways, a worse problem. Earlier,
01:09:55.740
you alluded to Prader-Willi. What is the genetic defect in Prader-Willi, and what's the phenotype?
01:10:01.340
So Prader-Willi is a genetic disorder in which, rather than having a single gene affected, there's
01:10:09.100
a region of the genome which is, in most instances, not all, but the majority of instances, deleted.
01:10:15.660
So there's a region of chromosome 15 in which there is a large deletion that is a region that has normally
01:10:25.900
20 or so genes in it. And when deleted, when the paternal, the father's copy of this
01:10:35.180
interval is deleted, the individual becomes, has a very characteristic phenotype. The maternal,
01:10:42.940
the mother's copy, is not expressed. This is called an imprinted region of the genome, which again,
01:10:49.820
for technical reasons, the only one chromosome expresses the genes from that interval. And in the
01:10:57.900
Prader-Willi region, the maternal genes are silenced. So they're there, but they're not expressed.
01:11:03.820
And if you do... So the mom could be a silent carrier.
01:11:06.380
The mom could be a silent... Carrier is not the right term.
01:11:10.540
Almost all of these individuals are... All of these individuals are the result of
01:11:17.180
spontaneous deletions that occur after conception. So it's not... So it's sort of polygenic,
01:11:25.180
and you can have... So the one example that is in my world that I get is familial hypercholesterolemia.
01:11:32.620
It's a phenotypic description. There are at least 2,000 known mutations, distinct mutations,
01:11:39.740
that can produce the same phenotype. So in that case, no one really... I don't want to say nobody
01:11:45.420
cares, but it's a lot less interesting to try to map out each and every one of the genes that can
01:11:50.460
lead to familial hypercholesterolemia. It's more important to understand the phenotype and how to
01:11:54.940
treat it. I'm guessing Prader-Willi is not quite that diverse, but is it safe to say, if I'm
01:12:00.620
understanding you correctly, that you could have two patients with Prader-Willi that will have different
01:12:04.380
genes? There are rare instances of Prader-Willi in which the number of genes deleted, rather than
01:12:12.700
being that large interval that I mentioned, include only three genes, but they're still in the region
01:12:18.540
which is deleted in the large deletion patients. So... So they're necessary and sufficient genes.
01:12:25.020
Yes. We think that those... that smaller region probably has the necessary and sufficient genes,
01:12:31.900
although again, there's debate in the field about this. The children, though, who are affected with
01:12:38.060
this disorder have very characteristic phenotypes. They actually don't grow well. They don't feed well
01:12:43.420
early in life. They actually have failure to thrive. They don't... they're floppy and hard to feed and
01:12:52.300
not very responsive in terms of ingestive behaviors. And then, again, for reasons that are entirely
01:12:59.820
unknown at this point, between the ages of four, five, three years of age, they become hyperphagic. They,
01:13:08.220
again, the drive to eat becomes very, very strong. These are some of the most tragic stories I've ever
01:13:14.860
heard. These children who I've never taken... I'm not a pediatrician, so I've never taken care of them,
01:13:19.740
but I've talked to parents of children. They have to lock the refrigerators. I even had one parent tell
01:13:25.980
me that they actually have to lock the bathroom because the child is so hungry, so hyperphagic,
01:13:31.500
that he would go into the bathroom to try to eat out of the toilet. It's true that in the majority of
01:13:36.780
instances, these children require very close scrutiny of their access to food. And in many instances,
01:13:44.780
the parents or caretakers have to resort to locking up whatever food would otherwise be available to
01:13:53.260
the children. But I think it's important to point out that there are ways of managing this disorder,
01:14:00.220
which has other characteristics. There are many endocrine disturbances that go along with it,
01:14:05.980
including actually growth hormone deficiency. And administration of growth hormone to these
01:14:12.380
children and various other sort of interventions that require a great deal of parental attention,
01:14:19.900
no doubt about that. Some of the severity of the disease is manageable at a clinical level with very
01:14:26.460
high levels of scrutiny by the people who are taking care of them. So that not all children with
01:14:33.020
Prader-Willi will necessarily become hugely obese or suffer the consequences of severe obesity.
01:14:40.540
This is one of those things where I hope, I know there are folks out there trying to raise money to
01:14:44.860
do clinical trials in this because anecdotally, again, there are these very interesting stories.
01:14:49.820
The first I ever heard of this was probably four years ago. I was giving a talk. I don't even
01:14:54.140
remember where it was. It was in Chicago, but I can't even recall the audience. But afterwards,
01:14:58.300
a woman came up to me and I was giving a talk about, I don't know, longevity, like it wasn't an obesity
01:15:04.860
specific talk or anything like that. But a woman came up to me and introduced herself and said her
01:15:08.540
son had Prader-Willi and was going off the rails, et cetera. And at about the age of seven or eight,
01:15:14.140
she put him on a ketogenic diet. And it corrected the phenotype, including the cognitive developmental
01:15:22.220
part, which often accompanies this. She then, I guess, since that time had formed kind of a support
01:15:29.020
group and you had more and more of these parents that were putting their Prader-Willi kids onto
01:15:34.140
ketogenic diets. Again, it's very difficult to draw much of a conclusion when you don't have controlled
01:15:39.500
data and you have obviously the selection biases that go into these things. But it struck me as very
01:15:45.180
interesting. Do the Prader-Willi kids, are they hyperinsulinemic? They are hyperinsulinemic to the
01:15:52.860
level that would be anticipated based on their degree of adiposity. And in some research that
01:16:01.260
we've done very recently using some of the stem cell techniques, or at least using stem cells that I
01:16:07.260
alluded to much earlier, we've got some evidence that suggests that one of the major consequences of
01:16:17.740
deleting this region of the chromosome 15 by mechanisms that are somewhat complicated
01:16:26.060
influence the expression of an enzyme called proconvertase 1. And this enzyme is critical for
01:16:35.260
for the processing of many of the hormones and neuropeptides that are made in the body.
01:16:42.060
Virtually all hormones and neuropeptides are made as pro-hormones, that is, precursor hormones
01:16:47.900
that are then processed by proconvertase 1. And that is what produces or generates the mature
01:16:57.420
form of the hormone or neuropeptide. And we think, actually, that the phenotype,
01:17:03.260
many of the phenotypes of the Prader-Willi patients may, in fact, be due to a deficiency or under-activity
01:17:11.420
of proconvertase 1, which is not in the interval where this deletion occurs, but is influenced downstream
01:17:18.860
by one or another of the genes in that interval. And it's relevant in the question of insulin, because
01:17:27.020
insulin is processed by proconvertase. So, some of the-
01:17:30.780
That's where the C-peptide gets cleaved off the pre-hormone.
01:17:33.340
That's correct. So, some of the hyperinsulinemia of the Prader-Willi might be pro-insulin.
01:17:41.660
Proinsulin has biological activity, but much lower than native insulin. And so, if this turns out to
01:17:49.660
be the case, then it might be possible to rectify some of the Prader-Willi phenotypes by
01:17:57.100
by being able to increase the activity of proconvertase 1, pharmacologically or by other means.
01:18:04.460
So, there's all this incredible work, all this incredible molecular biology and molecular
01:18:08.780
genetics that's identified leptin deficiency, leptoreceptor deficiencies, the cluster of defects
01:18:14.620
that lead to Prader-Willi. And yet, the question is, how much do these things tell us about the more
01:18:21.980
broad condition of obesity that afflicts, I don't even know the stats, I don't really keep track
01:18:27.740
of this stuff anymore, but I don't know what, a third of Americans are probably obese now?
01:18:33.580
So, I'll tell you, an interesting perspective on that question is, and I mentioned it earlier,
01:18:40.620
while we were doing the efforts to clone these genes, I was studying patients in the clinical
01:18:47.100
research center with Jules Hirsch, Mike Rosenbaum, long-standing associates. And what we were doing
01:18:53.740
is looking at the metabolic consequences of weight reduction and showing that if you reduce the body
01:18:58.940
weight of a human by 10%, 20%, you get a reduction in energy expenditure, which is greater than what you
01:19:06.220
would predict from the loss of just body size or that they're...
01:19:10.700
In other words, their metabolic rate didn't reduce just to support the new reduced weight,
01:19:15.980
it reduced even further, which would almost try to return them to a heavier weight.
01:19:20.700
Right. So, they had a disproportionate reduction in energy expenditure, and some of the data
01:19:27.900
suggested that the major change in energy expenditure was not in resting metabolic rate,
01:19:34.460
but in the energy cost of low levels of physical activity, of muscle work, so to speak, but at very
01:19:41.820
low levels of activity. And we went on to show that, as you would expect, based on a lot of what we've
01:19:51.180
been talking about, the leptin levels were low in these individuals, low but proportional to the
01:19:56.460
reduced amount of body fat. So, one hypothesis that we had is that this reduction in energy expenditure
01:20:02.380
was, in fact, a reflection of the fact that the body was sensing the reduction in low in leptin and
01:20:10.060
interpreting that as a starvation state. That is, for that individual, that new lower body weight
01:20:16.860
represented a threat, if you will, to survival or reproduction. And we've done experiments
01:20:23.180
subsequently in which we've injected leptin into those individuals. None of them has a genetic
01:20:28.620
lesion of leptin gene. So, they're just weight-reduced.
01:20:30.700
They're just weight-reduced normal individuals. We've put leptin back into them by injection to
01:20:37.260
raise the blood level back to where it was before they lost their body weight. So, these are very low
01:20:42.540
doses of leptin. And that intervention will restore their energy expenditure back to where it was before
01:20:51.500
they lost the body weight, even though they're now still maintaining the lower body weight.
01:20:57.340
So, put this in some quantitative terms for me. That infusion of leptin gave them how many more
01:21:04.700
kcal per day in energy expenditure, all things equal between movement, activity, et cetera?
01:21:10.780
You're talking about 100 kcal a day? Like, what kind of a delta are you producing?
01:21:14.140
Two or 300, because these are big people to start with.
01:21:19.260
Right. And we could show that that effect is primarily being conveyed through skeletal muscle.
01:21:25.180
So, what happens is that the muscle becomes less efficient, if you want to think about it that way,
01:21:33.820
So, there are two ways that we broadly in the research setting measure energy expenditure,
01:21:39.340
indirect calorimetry and doubly labeled water. Can you spend a second explaining each of those?
01:21:44.700
So, indirect calorimetry is really classical physics, if you will, in which the rate of oxygen consumption
01:21:54.060
and the rate of carbon dioxide are measured in a number of ways. The most frequent is to put a mask or
01:22:02.460
hood over the head of the individual in whom the measurement is made and simply use gas sensors and flow
01:22:09.340
meters to quantify the amount of oxygen consumed and CO2 released. And from that information,
01:22:17.100
one can quite easily calculate how many kcals of energy are being expended to correlate, if you will,
01:22:25.980
to account for the amount of oxygen consumed and the CO2 produced. And by looking at the ratio of
01:22:32.220
those two, one can even get a indication of the kind of fuel that's being burned to support the
01:22:41.980
So, the V, and I'll just spit it out, so folks can, if they're, we'll link to all of this stuff,
01:22:47.180
but the RQ or the respiratory quotient is the ratio of CO2 produced or VCO2 divided by
01:22:54.620
the amount of oxygen consumed or the VO2. And that'll vary sort of between, you know,
01:23:02.140
You can see it outside of those ranges. The lower it is, the more they're partitioning and drawing
01:23:07.420
from fat. The higher it is, the more they're drawing from glycogen. Correct.
01:23:11.980
And if I still remember my Weir coefficients, energy expenditure is something to the effect
01:23:16.460
of 3.94 times the VO2 plus 1.11 times the VCO2. Well, your memory is better than mine, right?
01:23:23.980
I can't recite you the Weir equation off the top of my head.
01:23:26.780
You know, it's really funny. About five years ago, I asked Kevin Hall to send me
01:23:31.100
the derivation of it, and it was so great to get this page, two pages of differential equations,
01:23:38.620
so I could go through and actually see how the Weir coefficients were described.
01:23:43.100
Which, of course, then led to the inevitable question that you and I have talked about in
01:23:45.980
the past, which is, do those coefficients hold in the presence of radical dietary change,
01:23:52.700
such as, you know, a very, very low-fat, high-carbohydrate diet, or the opposite.
01:23:57.660
So then, if that's how indirect calorimetry works, and of course, by the way, these things happen in
01:24:02.700
metabolic chambers. That's the ultimate way to do it, right? Where you can put a person into a room,
01:24:06.380
and the room itself has all of these sensors embedded in it.
01:24:09.980
Right. And that's exactly the same principle, but there, the individual's not restricted in
01:24:14.780
terms of their motion, other than in the room that they're in. So you can get exactly the same
01:24:20.380
information, but over a much longer period of time. I mean, you can do it for days.
01:24:24.060
There was a point when I wanted to build one of these at my home. I was so obsessed with knowing
01:24:29.820
every... I wanted to know, like, my VO2 and VCO2 almost every minute of the day. And then I found
01:24:35.820
out it would cost at least five million to build one and realized I couldn't build one. But I thought,
01:24:39.420
boy, if I ever make enough money to build one of those, that's a great fun... That's like,
01:24:45.100
that's fun for the whole family, if you really stop to think about it, you know? I mean, who wouldn't
01:24:49.020
want to go sit in the metabolic chamber on the weekend, just kicking it, watching football?
01:24:53.660
We just built one of these actually at Columbia, and it's quite a... You're right. It's not only
01:24:59.900
expensive, but requires a great deal of attention to things like leaks and airflow and...
01:25:10.860
So you'll recall, I used to spend time in these chambers, and I guess I exceeded the level of
01:25:15.980
CO2 production that it was sort of calibrated for because I was on my bicycle, and I was riding
01:25:20.540
pretty vigorously, and the CO2 sensor broke. And it's one of those things where you don't get a big
01:25:25.500
red flag. It was just after the fact that data didn't make sense. And this is where you appreciate
01:25:29.500
what you're saying, which is the engineering in this thing is amazing. And so you got to pour through,
01:25:34.460
you know, the longest spreadsheets in the world to start to look for where the mistakes are.
01:25:38.780
But it's really beautiful stuff. And there's not many of these in the country. Like, there's...
01:25:43.260
Obviously, Columbia has some. NIH has some. TRI has some. Pennington has some. Baylor has some.
01:25:52.780
Like you said, they're tricky to construct and require high level of attention to their
01:25:58.700
maintenance and operation. It's not just like going down in your basement and measuring your RQ.
01:26:05.340
So how does doubly labeled water work, which I also have had the privilege of ingesting?
01:26:10.540
So doubly labeled water is a technique which uses two isotopes of water, which is H2O.
01:26:20.220
In one, the oxygen is a heavier version of the normal or the more prevalent oxygen molecule. And the
01:26:29.660
other, the hydrogen is a heavy atom as opposed to the more prevalent kind of hydrogen in the environment.
01:26:39.740
And what you do is you can give these as a mixture. You have to know exactly how much of each one you've
01:26:45.820
given. But you can give this as a drink, basically, of what amounts to heavy isotope labeled water.
01:26:53.500
And then look at the relative concentration of these two isotopes. You can do it in blood. You can do it in
01:27:02.540
urine. We often do it in both. And the difference in the rate of excretion of the so-called O18 water, the heavy isotope of water,
01:27:13.180
which is oxygen is borne out both in urine, but also in the expired air of an individual as carbon dioxide.
01:27:23.020
And the H2O, which comes out by non-respiratory means, you can actually get a measure of how much CO2
01:27:32.940
the individual is producing. And you can use that and the nature of the diet that the individual is on
01:27:42.540
to back-calculate from what would be the RQ back to the oxygen consumption.
01:27:51.380
So the FQ is if you stuck the person's food into a bomb calorimeter, burned it, that would produce the RQ.
01:27:58.140
So the limitation of this is a couple things. One, the patient's got to be weight stable, right? This
01:28:05.180
starts to fall flat when they're losing or gaining tremendous amounts of weight. And two, you have to
01:28:10.680
have a pretty darn good idea of what they're eating. So each of these methods, ingenious and completely
01:28:16.100
distinct, both have huge limitations. The former, of course, requires an artificial environment. They
01:28:22.820
don't get to be free living. And you can't really study them for that long. But the latter, where they
01:28:28.600
can be free living and you can study them for, you know, two weeks at a time with a single ingestion
01:28:33.680
of the doubly labeled water, you better make sure that they're not gaining and losing weight. And you
01:28:38.380
better make sure you know exactly what they're eating. And in an ideal world, it better be the same
01:28:44.060
And in general, because of the issues that you just mentioned, I think most investigators in
01:28:52.620
this field prefer, at least in terms of its nominal accuracy, the room calorimeter over
01:29:00.740
the doubly labeled water. But the doubly labeled water does have the virtue, as you pointed out,
01:29:06.580
of being applicable over much longer periods of time so that you can get integrated idea of
01:29:13.540
how much energy an individual is expending over literally days or even weeks. What's sometimes
01:29:20.800
done is to re-dose the individual at some point in the experiment and simply continue it.
01:29:27.600
So when I did this, I did several days in several chambers and then separately did the LW.
01:29:34.500
I was kind of amazed at how closely they overlapped. Of course, it was hard to replicate my chamber
01:29:40.520
activity in the real world because there's so much more, you know, movement outside of the chamber,
01:29:46.500
but they were surprisingly in line, which is interesting because at the time I was on a
01:29:50.900
ketogenic diet, which there's a lot of things that could be changing there. So I want to go back to
01:29:57.080
something that we kind of got into a little bit, but it's, to me, it's one of the most fascinating
01:30:00.940
discussions slash debates, which is the idea of appetite being regulated centrally versus peripherally.
01:30:10.360
And you and I have had some incredible dinners having these discussions. And I've always found
01:30:17.260
your perspectives to be interesting because I think few people are more qualified to talk about
01:30:23.480
that in that they know so much about both. I mean, in many ways, leptin at its inception was really
01:30:31.040
viewed as a peripheral way to regulate appetite. So let me explain what I mean by that for the listener.
01:30:36.500
When you're hungry, are you, is this all being driven by what your brain is saying?
01:30:42.260
Is it possible that somewhere outside of the brain, which we refer to as the periphery, your liver,
01:30:47.500
your fat cells, your muscles, the level of blood glucose that's circulating, is there some other
01:30:52.720
signal? You know, it's kind of interesting that here we are in the year 2018 and it's still not
01:30:59.200
entirely clear where appetite is regulated. So how has your thinking on this topic evolved?
01:31:06.500
through your own immense knowledge of both the central and peripheral components of appetite.
01:31:13.760
You want to take a sip of that Topo Chico before you try to answer that? For the listener,
01:31:17.840
I've introduced Rudy to Topo Chico today. So he's, one sip into it, he declared it the finest bottled
01:31:23.000
water. I would describe the system, you know, from high altitude as the following, that there are
01:31:29.580
CNS, central nervous system mechanisms. They're not all in the hypothalamus, but many of them are. And
01:31:37.600
many of those that aren't do interact with the hypothalamus. And that that can be regarded,
01:31:43.960
that organ or set of cells can be regarded as the integrating center for basically the reception of
01:31:54.200
signals that are of relevance to how an organism ought to respond to its environment in terms of
01:32:01.380
food intake and also for control of some of the aspects of energy expenditure that are not necessarily
01:32:10.880
under voluntary control, such as autonomic nervous system. And what's coming into that system
01:32:17.440
is, I think, broader than we had originally anticipated. So clearly, leptin is an example of
01:32:26.280
a hormone that's secreted from adipose tissue. But there are many other peptides, actually,
01:32:32.080
or hormones that come out of adipose tissue. There are neural signals that are now being identified.
01:32:40.120
That is, nerve-borne signals that look like they're coming out of and going into adipose tissue that may be
01:32:46.820
playing a much more important role than we had sort of previously appreciated. The gastrointestinal
01:32:53.220
tract, which for obvious reasons is a very relevant aspect of the system, originally was, I think,
01:33:01.680
regarded pretty much the way that adipose tissue was, as a tube that absorbed your calories and didn't
01:33:08.160
really participate actively in the regulation of that aspect of biology. Clearly, the advent of
01:33:16.820
various surgeries for control of body weight have indicated that that sort of premise is
01:33:23.620
incorrect. That is, that there are very powerful influences of the gastrointestinal tract, which are
01:33:29.020
brought out by some of the surgeries that are done. And it's now very clear that the gastrointestinal
01:33:35.380
tract, at many levels, is communicating with the brain, both by products that it secretes and by direct
01:33:44.320
neural input, probably primarily, but not entirely via the vagus nerve into the brainstem and then
01:33:51.420
further up into the brain. So just, you know, taking that as a sort of very broad picture,
01:34:00.180
it's much clearer now that there is no sort of single definitive part of the biology of an individual
01:34:10.500
which is dictating this very complex system. It's really a product of the interaction of these
01:34:16.300
peripheral signals, as you referred to them, including metabolites, such as glucose and free
01:34:22.400
fatty acids and so forth, and the central nervous system, not just the hypothalamus, but areas like
01:34:29.660
the brainstem, the amygdala, the frontal cortex. There's many other areas of the brain that interact with
01:34:35.320
these signals to influence both the behaviors and the unconscious, if you will, the vegetative
01:34:42.680
responses that ultimately go into the regulation of body weight. So I think it's obviously a very
01:34:50.980
complex and overdetermined system. And it's that way because it is absolutely critical to survival.
01:34:59.440
So it's not surprising in a way that it's as complex as it is. But I think what it clearly does is it
01:35:06.680
introduces all sorts of possibilities for mischief with regard to body weight regulation, starting in
01:35:14.940
the frontal cortex where decisions are made, at least with regard to some aspects of this, all the way down
01:35:21.180
into the colon where you've got large numbers of bacteria that are producing things, metabolites and
01:35:28.340
molecules themselves that, again, we're only just beginning to understand. So we're not only talking
01:35:35.140
about a regulatory system that has all of these elements, but a bunch of organisms literally living
01:35:40.900
within us that are influencing it in ways that I don't think we've really fully understood. The
01:35:46.940
miracle is actually when you think about all the ways that it could go wrong, that it doesn't go wrong
01:35:53.640
anymore than it actually does. And it looks to me like the major problem in terms of the obesity that
01:36:03.180
you referred to earlier that's increasing has to do a great deal with the environment and what people
01:36:09.740
are being exposed to that's very novel with regard to the system. I mean, this system was not designed
01:36:16.840
for the regulation of metabolism and body weight in an environment in which, with a cell phone, you can
01:36:24.200
bring literally as many calories as you want into your living room without getting up off your behind.
01:36:32.940
So we're dealing with an organism which has this very complex and beautiful system designed to regulate
01:36:39.420
various aspects of the biology, which is now in an environment which is entirely, at least in many
01:36:46.440
regards, novel to the system. And it fails in the sense that there's a lot more obesity than there was
01:36:55.240
prior to the environment that we've been able to create. But it's not totally dysregulated. I think people
01:37:04.400
are just now regulating their body weights at somewhat higher levels than they were in other
01:37:12.480
Again, I don't follow the statistics. It's not something I'm paying huge attention to. But
01:37:16.840
are the rates of obesity plateauing or are they still increasing? Or is the curve concave up or concave down?
01:37:24.140
So several years ago, it looked like the rates were either slowing down or level. Now it looks like maybe
01:37:32.000
they're continuing to inch up, but not as rapidly as they were, say, a decade ago. So there's been
01:37:38.040
some relenting of the rate of increase, excuse me, in obesity in both adults and children. But it
01:37:45.960
looks like it's still rising, although at a lower rate.
01:37:50.420
Do you have concern that there are epigenetic implications of this, that 10,000 years ago,
01:37:57.880
the prevalence of obesity, again, largely probably driven by the environment that made it pretty
01:38:04.800
hard to become obese? Not just in terms of food availability, in terms of absolute calories,
01:38:09.940
but presumably the types of calories that were available. I mean, I think my recollection is that
01:38:14.720
10,000 years ago, nothing came in a package, right?
01:38:18.660
So we didn't have Pop-Tarts, we didn't have breakfast cereal, we didn't have orange juice,
01:38:26.800
we didn't have French fries and whatever else are the culprit potentials. So if Johnny got a set of
01:38:34.160
genes that were slightly suboptimal, Johnny Jr. probably got some of those suboptimal genes, but
01:38:41.460
there was nothing being imprinted on the genome that was being transmitted to generations. And
01:38:48.620
I mean, what do you think about this idea that we could be reaching kind of a dangerous point
01:38:54.600
in the evolution of our species where children, maybe during critical windows of development,
01:39:00.800
if exposed to, you know, again, in my opinion, it's probably a lot of the sort of really highly
01:39:06.660
refined crap, high amounts of fructose that we're seeing with the NAFLD, that this is setting them up
01:39:12.480
for a real problem later in life. It's going to make it a lot harder, not just for them to lose
01:39:17.260
weight one day, but also for their offspring. Is there any evidence of that?
01:39:21.940
I think there is evidence that's, I'm not so sure I would use the term imprinting. That has
01:39:29.020
sort of specific biological meaning and implications. I mean, we could talk about that in a minute, but
01:39:35.800
if what you're saying is, are there perhaps critical periods of development in a child in which if the
01:39:47.180
child is caused to become more obese than he or she might be in some other environment, that that will
01:39:54.960
leave a mark on the regulatory system that will then cause that individual to want to sustain or
01:40:01.900
maintain a higher body weight? I think the answer is probably, or at least possibly yes. That is that
01:40:09.760
there may be critical periods in human development. Certainly, I think the data are also available to
01:40:19.520
some extent in animal studies that suggest that if you manipulate body weight or some of these systems
01:40:27.060
at critical periods of development, you end up with an animal which is more likely to be obese as an
01:40:34.940
adult than if you hadn't done that. And exactly what the molecular and neuroanatomical or other
01:40:43.580
physiological consequences of that manipulation are that lead to the maintenance of a higher body weight,
01:40:51.780
this is obviously a critical area of study. It's actually something that people in my lab are quite
01:40:58.940
interested in. That is whether we can impose by dietary or other manipulations a higher body weight
01:41:06.500
or a higher sustained body weight in an animal by early manipulations, either by diet or endocrine
01:41:13.960
manipulations. And I think the answer is probably yes. But what is the consequence of that in terms of the
01:41:23.120
regulatory elements that we were talking about? We don't yet know. Another aspect or another perspective
01:41:31.520
on this is the following question. If you manipulate the metabolism of a pregnant animal or human,
01:41:40.540
what are the consequences of that on the developing brain or physiology of the fetus?
01:41:48.200
I mean, there's evidence now that a mother who is hyperinsulinemic or has gestational diabetes is
01:41:54.700
increasing the child's risk of obesity. Is that not the case? There are data that suggests that-
01:41:59.860
It's registry data, so it's hard to know. Right. But that obesity in a pregnant woman does confer
01:42:08.020
by, again, by mechanisms that we don't understand, higher risk of obesity in her offspring.
01:42:16.240
Although I'd love to see it stratified by hyperinsulinemic versus non-hyperinsulinemic obesity.
01:42:21.740
Because I feel like I remember reading that it also seems to be dependent on the gestational stage.
01:42:28.280
In other words, like when the dorsal and ventral buds of the pancreas are forming,
01:42:32.640
which I can't even remember when that is, maybe week seven, eight, nine, something like that.
01:42:36.060
Those are very critical windows, right? That's when islet cell formation is taking place and
01:42:41.560
nutrient exposure or insulin exposure during that period of time could have a more profound effect
01:42:46.520
than say late in the third trimester where perhaps it's not as effective. Again, very, I mean, I'm just,
01:42:52.680
I don't follow this literature, so I don't want to sound like a complete moron. And the last time I
01:42:58.080
really paid attention to this stuff was probably four years ago. And it was, again, largely registry-based
01:43:02.880
data, so very difficult to know cause versus effect.
01:43:07.500
Again, you know, the literature, as you sort of implied, is wobbly on this point. But I'll just
01:43:14.900
tell you about a couple of experiments, actually, that we've done. One to answer, to address this
01:43:20.200
question of hyperinsulinemia in a dam, in a pregnant animal, and its effects on the fetus.
01:43:27.520
We were able to do an experiment in which we were interested in separating the issue of
01:43:34.140
high body weight and adiposity from the effect of insulin itself. And so we actually used a genetic
01:43:42.480
model of hyperinsulinemia and were able to make the dams hyperinsulinemic without being obese.
01:43:48.300
So these are perfectly normal body weight dams that were very hyperinsulinemic. And the pups that
01:43:55.720
they were carrying, some of those pups had no abnormality of any insulin-related genes. So they
01:44:02.620
were what we would call wild-type pups being incubated in a hyperinsulinemic dam. And we were very
01:44:08.980
interested to see what the consequences would be on the metabolism and body weight of these animals.
01:44:14.200
And very interestingly, these animals showed transient elevations of body weight and body fat
01:44:24.700
when they were in what I guess we would describe as adolescent period of a mouse, which tended to
01:44:31.980
revert back to normal over time. You could definitely see an effect in the body weight and metabolism of
01:44:39.560
the mouse, but it appeared to be transient. And to be clear, the mother was euglycemic?
01:44:46.040
The mother was euglycemic and hyperinsulinemic. That's a tough needle to thread, my friend.
01:44:51.040
Yes. So again, it's the power of genetics. So we could do that. So these kind of experiments,
01:44:55.760
we also looked at the brains of these animals, and there were some very subtle differences in the
01:45:00.480
way the hypothalamic cells, the numbers of different types of hypothalamic cells, which suggested
01:45:05.940
in sort of support of the inference of your implication of your question, there are consequences
01:45:14.180
of these metabolic states of the dam that can influence the subsequent development of the pup,
01:45:21.320
even if the pup doesn't have the genetic etiology that led to the derangement, if you want to call
01:45:27.980
it that, in the dam. We've more recently been doing some experiments along these lines looking at
01:45:33.500
leptin in a similar way, and again, can see evidence of influence, long-term influence of
01:45:40.060
manipulations of leptin in this way, which again suggests that these transient periods of exposure
01:45:46.640
at various levels or various periods of development can have long-term consequences for organisms that
01:45:54.840
don't themselves have any primary abnormality of these genes or their functions.
01:46:01.720
So I think this probably supports the notion that there are things going on in the environment
01:46:08.080
that are not reversible once the environment is necessarily reversed. That is, the exposure to
01:46:15.040
the environment may change the biology in such a way that even when the insult, if you want to call
01:46:21.780
it that, is removed, the biology is permanently impacted.
01:46:27.120
We've spent a long time talking about low-carbohydrate diets. You were part of one of the
01:46:33.620
studies that was funded by NUSI, and while the study that you were a major part of was not a diet
01:46:40.320
study, so I wasn't really looking at diets, it used diets as a tool to ask questions. Clinically,
01:46:46.240
we know that low-carbohydrate diets are very effective. I think it would be very difficult for
01:46:50.940
people to dispute that at this point in time. The interesting question, if you're rudely liable,
01:46:57.580
is why? What do you think? Why do these diets seem so effective for so many people? Let's not even
01:47:04.700
get into the fancy stuff about the diabetes reversal and stuff like that, where I think
01:47:08.560
the results are especially pronounced, but just in terms of obesity reduction, why do you think these
01:47:13.400
things work? I guess my view of this is that to the extent that diet composition has an effect on
01:47:21.460
body weight, which clearly it can, that this is the result of the interaction of the components of
01:47:33.000
the diet with aspects of the regulatory control of food intake. I guess the way I describe this is
01:47:41.220
the sort of hedonic aspects of the food that's being ingested will influence the drive to ingest that
01:47:51.680
particular food. I think individuals differ in terms of their sensitivity or susceptibility to diets of
01:47:58.360
different composition, and there clearly are some individuals who, when fed or offered or impose
01:48:07.360
diets that have pretty radical compositional differences, will respond very well. In other
01:48:15.620
words, there are people who respond well to high-carb diets, there are people who respond well to low-carb
01:48:20.740
diets. I think that it's primarily some aspect of the hedonics of these diets, if you want to call it
01:48:29.720
that, that's driving the favorable response. I know, and I'm sure you and I have discussed this many, many
01:48:37.260
times, there are individuals who view the diet composition as having, in addition to what effects
01:48:44.160
I just described, also an impact on energy homeostasis itself, meaning that the composition of the diet can
01:48:51.900
influence the degree of caloric expenditure per unit of calories ingested. I'm not a sort of strong
01:49:01.820
proponent of that view. I guess I try to remain agnostic about it, but my bias, if you want to call
01:49:09.340
it that, from my experience is that that's right. Diet composition can have an effect on body weight. It
01:49:15.840
doesn't do so by effects primarily, or maybe at all, on energy expenditure per se, but can have pretty
01:49:24.540
striking effects on an individual's desire to eat those calories delivered in that form.
01:49:31.580
And so, there's two ways to think about that, right? Again, if you leave the energy expenditure side
01:49:36.140
away, on the intake side, is it the case that a low-carbohydrate diet, as you say, it's purely a hedonic
01:49:43.020
issue. People just, when they're on these diets, they're just not as hungry because, I don't know,
01:49:47.280
the food is not as diverse or not as palatable. An alternative viewpoint is they eat a lot less
01:49:52.200
because they're eating themselves more. In other words, they're, you know, the way I try to explain
01:49:56.220
this to my patients when we're talking about nutrition is, you want to differentiate between
01:50:00.960
exogenous and endogenous calories. So, you know, most people walk around, if they're weight stable,
01:50:06.640
purely subsiding on exogenous calories. But if you want to lose weight, by definition,
01:50:11.340
you must start to consume endogenous calories. You have to start eating yourself.
01:50:16.480
And this gets back to the question of the regulation of body weight peripherally. If you
01:50:23.620
are eating yourself, can the CNS figure that out and say, hey, we've got all this lipolysis going on.
01:50:30.620
We're liberating all of this fat out of a fat cell. That's energy. Fantastic. I will program the
01:50:38.180
system. You need less exogenously. So those are two kind of very different ideas, right? The one is
01:50:43.680
just, hey, this food is boring and doesn't taste great. I'm just going to eat less of it. Personally,
01:50:48.540
I don't find that theory as appealing because having worked with so many patients that do this,
01:50:53.000
if that were the case, I'd suspect they'd be more hungry, but yet they don't seem to be very hungry,
01:50:58.320
which is, I think for most people, the only thing that's intolerable over long periods of time is
01:51:04.540
hunger. You know, you look back at the Ancel Keys starvation experiments and those guys weren't
01:51:09.700
really like, you know, what they were eating, like what, maybe 1600 calories a day, but they were
01:51:13.900
losing their minds, right? I mean, these guys lost their minds on 1600 calories per day. So
01:51:20.820
starvation is clearly an unacceptable state in the long run. I got to be honest with you. I'm glad I
01:51:27.080
don't work on this problem. I'm much more interested in just trying to figure out this other easy
01:51:31.100
problem of longevity. But this obesity thing is a real bear. Because at the same time, as much
01:51:37.460
success as I've seen for people on low carbohydrate diets, I also know that they don't work for
01:51:41.360
everybody. And therein lies the challenge of why? Why would something, I mean, again, it's a naive
01:51:50.520
question in the sense that you've just spent the last two hours explaining some of the most complex
01:51:55.480
biology of obesity. Why should everyone respond to the same treatment? But it does. It really frustrates
01:52:04.020
me that there are certain patients in which no matter what one does or no matter what they do,
01:52:09.580
you know, I think patients that try really, really hard and can't lose weight, I find that to be a very
01:52:14.420
frustrating clinical problem. So I guess maybe I should rephrase the way I answered your question.
01:52:21.460
And that is to say that I believe that the composition of the diet can influence aspects of
01:52:29.100
ingestive behavior. I emphasize the hedonic aspect, but I'm certainly open to the possibility
01:52:37.560
that if you feed a diet of, you know, divergent composition, you will definitely have some influence.
01:52:46.540
I mean, this is well documented on the substrates that are in the circulation as a result of feeding
01:52:52.440
that diet. Those substrates themselves, metabolites, you were mentioning fatty acid, but many other
01:52:59.020
things change, may themselves have a effect on the drive to eat. I'm sympathetic to that idea.
01:53:07.720
And exactly in any given individual who does or doesn't respond to a specific diet, which of the
01:53:14.380
mechanisms, you know, whether it's occurring at the level of the taste of the diet or some of the
01:53:21.960
metabolic consequences of the diet, I would say to the extent that somebody is successful in
01:53:27.840
losing weight on that diet, A, they have to be in negative energy balance. That is, there's no way that
01:53:33.860
they can eat the number of calories that they're expending and lose weight. So they need to be in
01:53:39.960
negative energy balance. And I mean, that's just a given. And then the mechanism by which the diet
01:53:46.460
composition influences the success of their ability to sustain a hypocaloric state, which as you pointed
01:53:53.400
out, is uncomfortable. I'm open to the possibility that it could be at any level of the sort of neural
01:54:01.920
circuitry that regulates food intake. It could be very proximal in terms of taste aspects, but it could
01:54:10.040
also be some of the mechanisms that you mentioned. I think that's perfectly reasonable. How that works,
01:54:18.100
as you pointed out, is a tough nut to figure out. And I think, like you said, there are individuals who
01:54:26.380
respond very well to diets of quite divergent composition, but they have to be taking less
01:54:33.240
calories than they are spending. Right. And that's an easy thing to do mathematically. It's a very hard
01:54:39.760
thing to do clinically because, again, I think patients can tolerate a lot, but I don't think
01:54:45.500
people can tolerate hunger for very long. I think to ask somebody to be constantly hungry
01:54:51.020
is a losing proposition. And that's why I believe clinically low carbohydrate diets seem to be more
01:54:59.000
satiating. And again, whether they're satiating because of something in their composition or whether
01:55:05.420
they're just satiating because you end up eating more of yourself. I mean, I've seen lots of patients
01:55:10.000
who, and this has even been published, who on 16, 1700 calories a day of a ketogenic diet seem
01:55:16.520
completely fine. And yet Ancel Keys' patients at 1,400, 1,500, 1,600, 700 calories of basically
01:55:22.640
very high carbohydrate diet, very low fat diets, lost their minds. What did you believe 10 years
01:55:29.860
ago that you don't believe today to be true? I think over the past decade, the field of the
01:55:37.280
sort of neuroscience of body weight regulation or ingested behavior and energy expenditure has expanded
01:55:44.040
the role of other elements in the central nervous system beyond what began as our very intense
01:55:52.680
focus on the hypothalamus. Partly that's historical and for reasons having to do with the tractability
01:55:58.920
of some of the cell types and mechanisms in the hypothalamus. But I would say the biggest change
01:56:04.760
in my thinking about this has been that these supra-hypothalamic aspects of the central nervous
01:56:12.660
system, again, starting with the cortex and working down, have a much stronger, I think,
01:56:19.500
ultimate impact on this regulatory system than the way I perceived it a decade ago. And what this does
01:56:27.000
is it opens up, I think, a lot of very interesting aspects of the biology that maybe we weren't either
01:56:34.560
capable of or didn't focus on adequately, part of which actually is in response to the point you were
01:56:40.840
just raising. That is, what is the effect of diet composition on hunger and so forth? It's almost
01:56:47.480
certainly an aspect of this sort of view of the broader central nervous system impact on ingested
01:56:55.700
behavior than just the hypothalamus. You know, my mentor, Jules Hirsch, I think, who unfortunately
01:57:02.820
passed away. He passed away about four years ago? Yeah, three years ago. He would agree with this. I
01:57:08.080
mean, he always, I think, was suspicious of focusing, you know, slavishly, if you will, on the hypothalamus
01:57:16.760
as the center for all of this. He always, I think, had a much broader perspective on some of the
01:57:23.180
psycho-affective aspects, as he would describe them, of ingestive behavior. And I think he would see the
01:57:30.160
sort of flowering of broader view of some of these regulatory aspects of food intake to other parts
01:57:37.600
of the central nervous system. He would say, I told you so. And he was right. I think he's looking
01:57:43.360
down at you saying that. Yeah, he's probably saying a lot of other stuff too. If we could wave a magic
01:57:50.200
wand and not only were resources unlimited, but more importantly, any of the technical considerations
01:57:56.600
that make this type of study challenging were just ameliorated, what's the dream experiment you
01:58:02.740
would want to do? If you got one more shot at this, you could spend the rest of your career
01:58:07.260
doing a dream experiment with infinite resources, infinite subject participation. Screw the ethics.
01:58:14.800
There's no IRB. You've got a bunch of clones out of Westworld. You can do whatever the hell you want.
01:58:19.420
What experiment do you want to do? Once to take your final kick at this problem.
01:58:26.600
There is a gene that was identified now 10, 12 years ago.
01:58:39.200
Right. It was identified by Mark McCarthy and some other investigators in Great Britain
01:58:44.060
as sending the strongest genetic signal for obesity or elevated body fat, not severe effect,
01:58:52.980
but the strongest statistical signal ever detected in humans. It remains the same.
01:58:59.880
The prevalence of the variants that are associated with higher body fat are very high in the general
01:59:06.180
population. So there are a lot of these variants of this gene that are contributing to
01:59:13.500
human obesity, not of the severity, certainly, of the OB or the monocortin-4 receptor.
01:59:21.480
There are various schools of thought about how this gene is doing it. The interesting thing is
01:59:26.480
that the variation in the gene that is conferring the risk of obesity is variation in what we call
01:59:34.260
non-coding part of the genome. So as people will know, a small fraction of the genome,
01:59:41.020
2% or 3% actually encodes the proteins that are made that we've been talking about, actually.
01:59:48.620
The rest of it is regulatory parts and elements that we don't understand very well.
01:59:54.340
The variants that are implicated for the FTO gene actually occur in the non-coding region.
02:00:00.880
We know exactly where they are. It's not a mystery where they are, but they're in non-coding. They're in
02:00:07.180
the first intron, so to speak, of this gene. The mechanism by which this very, very common variant
02:00:14.820
leads to subtle increases in body fatness in a large number of individuals. To me, this is a very
02:00:23.700
intriguing question. There are some that view the effect as being conveyed through what's called
02:00:30.800
browning of adipose tissue, increasing the energy expenditure of adipose tissue. There are others
02:00:37.220
like myself who think it's affecting central nervous system circuits that affect food intake,
02:00:43.680
but the mechanism, at least in terms of the central nervous system, is really unknown. The primary
02:00:50.780
phenotype that's seen in these individuals who do or don't have what we call the risk variance is food
02:00:57.300
intake. I mean, if you measure their food intake very carefully in a lab, you can see that the
02:01:02.820
individuals with the variants will eat slightly more. They actually may have a slight preference
02:01:08.080
for fattier, higher fat foods than individuals who don't, but what exactly is going on in the central
02:01:16.320
nervous system is not clear. They have actually, in one study, pretty characteristic functional magnetic
02:01:24.100
resonance imaging differences among individuals who do or don't have this variant, but the mechanism
02:01:31.540
is unknown. And this is something which has intrigued me now for eight or ten years. That's the experiment I
02:01:38.740
would love to do. I mean, we're actually trying to do it. Tell me specifically what the actual
02:01:42.700
experiment is, but before you do that, I want to make sure I'm, and this is going to be an oversimplified
02:01:47.400
analogy, but what you're basically saying is there's a genetic marker effectively that creates or
02:01:53.820
identifies those who are predisposed in a high nutrient environment to overeat. So even though our
02:02:01.240
ancestors would have had these genes, the reason, or nevermind our ancestors, even though a hundred years
02:02:06.220
ago or 50 years ago, this gene still existed, probably at the same prevalence, you didn't have the food
02:02:11.660
environment to pour fuel on that fire. Now, just to push back a little bit, isn't that sort of like
02:02:18.180
saying, we've got all these people getting lung cancer. It only started when they started smoking
02:02:23.560
and, you know, only one in 10 of these smokers are getting lung cancer. There's a gene that might be
02:02:29.160
predisposing them to lung cancer. So you're, you're basically saying, I want to look at the problem of
02:02:34.680
why are certain people susceptible to an environmental trigger versus what's the environmental trigger?
02:02:41.620
In the case of smoking, it was so obvious. It was the goddamn cigarettes. In the case of obesity,
02:02:50.520
So the experiment that I would do, and actually we're trying to do these now, is to actually look
02:02:57.160
in animals in whom the variants of the genes that we think are affected by this, because even though
02:03:06.680
the intronic region is not encoding anything, we think it's affecting genes that do encode something.
02:03:14.040
And we think we know at least what one of those genes is. And what I would like to see is what the
02:03:19.540
consequences of these variants are on the functional activity of the system that we think is mediating the
02:03:30.700
effects of these genes. Because I, again, for reasons that are quite technical, I think that one of the
02:03:38.620
major impacts of this gene or these variants in this gene is actually on the structure of the nervous
02:03:46.540
system. So I think their impact is occurring early in the development of the brain. And that what it's
02:03:54.540
doing is changing the circuitry slightly in a very maybe subtle way, probably subtle way, that favors
02:04:02.860
the increased food intake that you just described. And the implication of this is very relevant to some
02:04:13.640
of the things we were just talking about earlier. That is, can the environment impose permanent
02:04:20.680
signatures on the feeding circuits on the feeding circuits, so to speak. And this is, I think, a prime
02:04:27.120
candidate in that regard. And the virtue of the FTO study that we've been talking about is that we know
02:04:34.680
at least enough about the genetics and some of the mechanisms that we can design the experiments primarily,
02:04:43.560
but not totally, but not totally in mice to be able to look precisely at where the changes are occurring.
02:04:51.480
We now just coming online are the tools to look at the circuits as they are acting physiologically. We can
02:04:59.800
activate these circuits in the brain of an animal by using various neurophysiological and neurogenetic
02:05:07.720
techniques that will, I think, permit us to see where the structural consequences of these variants
02:05:15.400
reside. And my guess is that that would give us an insight into the sort of prevalent genetic
02:05:25.160
susceptibility or one of the prevalent genetic susceptibility.
02:05:27.560
What would we do with that information? Let's assume you had all of that information. How does that
02:05:32.440
take obesity from 35% to 5%? Well, you're asking somebody who is not
02:05:38.760
an epidemiologist. And I, you know, some of us do what we know how to do.
02:05:45.000
You're a hammer, you look for a nail. So I'm a hammer looking for the nail of whether or not
02:05:49.560
I can show a gene which alters the structure of the central nervous system in a developing organism
02:05:58.120
in such a way as to make it susceptible to the environment. The animals that we have studied
02:06:03.960
where we've manipulated this gene definitely are sensitive to the environment in the sense that they
02:06:12.280
will choose or eat more of a high-fat diet than a normal or, you know, a regular diet.
02:06:21.400
There are at least a half a dozen SNPs in the first intron.
02:06:31.000
And what is the prevalence in, to the best of our knowledge,
02:06:35.320
of people today who have at least one of these SNPs in that first intron?
02:06:42.280
So 60% of the population would be at least somewhat susceptible to obesity.
02:06:47.960
Yeah. Which is, you know, sort of fits with what we see because the effect size of this genetic
02:06:55.000
variation is not on or off. It just widens, I think, the, or increases the susceptibility
02:07:03.080
to whatever it is in the environment that's doing this.
02:07:05.800
Are there pharmacologic things that could be done to combat this?
02:07:09.240
Well, we don't know what it is, so we don't know.
02:07:11.320
Because we don't know what the, we don't know what the approach,
02:07:13.000
it's so much more complicated because it's non-coding.
02:07:15.080
Correct. But that's what fascinates me about it. And I think it's producing
02:07:19.880
something in the central nervous system which is structural in consequence, at least in part.
02:07:25.000
And that's why I'm fascinated by it. Because what this means is that if you have this
02:07:30.600
predisposition, it may change the nature of your central nervous system structurally in such a way
02:07:39.560
So if you take just hypothetically an animal that's born with these introns,
02:07:44.760
with this pattern of introns, and you could magically use CRISPR and you could delete them
02:07:49.320
and edit them and make them a wild type again, do you fix the phenotype? Because if not, that would
02:07:55.160
certainly point to something early on in neurologic development, right?
02:08:06.040
And sorry, it did or did not fix the phenotype?
02:08:08.680
Okay, so that means that it has an influence that transcends development, right?
02:08:13.320
That it's part of development. I mean, because the fix occurs at the level of the fertilization of the...
02:08:25.080
Right. So, Rudy, you're never going to stop working, are you?
02:08:28.120
All right. Well, if I got to figure this out, I'll have to stay at it for a little bit longer.
02:08:32.760
There are a lot of other things I want to talk with you about. Maybe we'll just spend a couple
02:08:36.040
minutes. There's something else I want to talk about, which is the most complicated topic ever,
02:08:41.720
insulin resistance. What the hell does insulin resistance mean? How can an insulin resistant
02:08:48.280
person be fat when, by definition, insulin needs to tell the adipocyte to take up the free fatty
02:08:55.320
acid as triglyceride? So does insulin resistance mean insulin resistance of the muscle, insulin
02:09:01.960
resistance of the liver, but insulin sensitivity of the adipocyte? What does that mean?
02:09:07.320
The metabolic disposition of glucose, for example, is obviously, or maybe not so obviously,
02:09:15.080
it's not primarily via adipose tissue. I mean, glucose, when it gets into the circulation and is
02:09:21.240
removed or taken up. It's mostly in the muscle. Yes. It's mostly in the muscle. So, to the extent
02:09:27.560
that insulin resistance is functionally denominated by elevated blood glucose.
02:09:36.120
It would seem to be the muscle is the primary defect. It would seem to be the muscle, which is the
02:09:40.520
primary defect. Now, the mechanism of the insulin resistance of muscle, I mean, this is an area that
02:09:48.280
is not one that I work in primarily, but there appears to be that what's going on at the sort of
02:09:57.080
distal end of the insulin resistance path is that the glucose transporters are not
02:10:04.280
getting to the surface. They're not responding to insulin the way that they do in a non-insulin
02:10:13.320
resistant person. And when the insulin transporters, the glucose transporters don't get to the muscle,
02:10:20.680
get to the surface of the muscle cell, they can't transport glucose. So at a molecular level,
02:10:26.600
depending on exactly whose model of this you look at, there's something wrong with the transmission of
02:10:33.160
the signal from the insulin receptor. Into the cell to send the glute transporter up.
02:10:38.680
Right. And exactly what that defect is, again, depends on who you talk to or what mechanism is
02:10:47.880
invoked. That appears to be, at least on one level, the sort of primary problem.
02:10:52.680
So what's happening in the liver? When we do an oral glucose tolerance test,
02:10:56.760
the reason we do it for such a short period of time, relatively speaking, aside from who wants to
02:11:00.840
keep a patient in the lab forever is, you pretty much eliminate de novo glycogenesis or you eliminate
02:11:06.760
DNL, right? So you're basically looking at uptake by muscle, but there's some being taken up by the
02:11:12.600
liver. And I don't know that I understand fully, aside from capacity, right? The liver has a relatively
02:11:19.240
small capacity for glycogen relative to the muscles. What else determines that partitioning of how much
02:11:25.240
glucose in the bloodstream is going into the muscle versus the liver? And then ultimately,
02:11:30.760
anything that exceeds those capacities will then undergo DNL and the de novo glycogenic pathway will,
02:11:36.280
you know, produce addition free fatty acid. And again, what does it mean to be insulin resistant in
02:11:41.400
the liver? So it's interesting. You know, the liver, if you want to look at it this way,
02:11:45.400
there are sort of two major metabolic things going on. There are a lot of things going on in the liver,
02:11:50.040
but as far as what we're talking about, one is the ability to make lipid, to synthesize lipid,
02:11:56.600
and the other is the ability to make or take up glycogen, to release or take up glycogen. They are
02:12:03.640
differentially sensitive to insulin suppression or enhancement, if you want to look at it that way.
02:12:11.640
And what happens, I mean, just again, at a biochemical level is you can get insulin resistant in the liver
02:12:19.080
to the suppression of gluconeogenesis while you maintain sensitivity to the effect of insulin on
02:12:30.760
Yes. But that's what happens. I mean, that's the state, I think, in many individuals who have
02:12:39.080
issues with regard to insulin homeostasis, if you want to describe it that way.
02:12:43.560
Yeah. So for the listener, what we're basically saying is the doomsday scenario would be
02:12:47.800
your muscles become resistant to the signaling of insulin and they don't put these glute transporters
02:12:53.240
up there and you don't bring glucose into your muscle.
02:12:55.240
Yeah. But why that happens actually, in other words, what is it about becoming obese that is
02:13:07.240
Well, it may be. I mean, again, this is an area of somewhat hot debate, but one possibility,
02:13:13.320
I guess, is that there's something that happens to adipose tissue when you store
02:13:19.160
whatever for that individual is an excess amount of lipid that's producing another molecule or some
02:13:26.600
other mechanism by which muscle is affected with regard to its insulin sensitivity.
02:13:33.960
The other possibility, which I think, again, many people think is at least partly relevant,
02:13:39.720
is that when you increase the amount of lipid in your adipose tissue, you also increase the amount
02:13:46.440
of lipid in your muscle, the fat that's in your muscle, actually, the marbling of your own muscle,
02:13:53.240
and that that itself has an effect on glucose homeostasis. So there's a whole...
02:14:00.520
What does Gerald Schumann think of this? Doesn't he have an idea that it starts in the liver?
02:14:07.640
So Gerald Schumann has done a lot of work on the mechanism by which insulin affects
02:14:15.400
glucose transport in muscle. I don't want to speak for him, I mean, in terms of what he
02:14:20.440
thinks about this, but he certainly is one of the people who I think has advanced the
02:14:26.600
field in terms of understanding why, for example, ambient fatty acids seems to suppress
02:14:34.200
glucose uptake in muscle. This was originally described by Randall.
02:14:38.440
And just to be clear, that's not Randall the patient.
02:14:46.040
So I think what Gerald Schulman has done is to advance our understanding of
02:14:50.280
a very, I think, compelling mechanism by which high levels of ambient fatty acid themselves
02:14:55.640
might suppress insulin signaling. Some of that fatty acid could, in fact, come from
02:15:02.440
lipid that's stored in the muscle as opposed to lipid or fatty acids that are in the circulation.
02:15:08.040
But there are these two different phenotypes, right? When you look at Cahill's 40-day fasted
02:15:12.760
subjects, their free fatty acids were through the roof. Their insulin was very low. Their glucose
02:15:17.880
was very low. Their ketones were very high. It's interesting to know, would you call them
02:15:22.440
insulin-sensitive or insulin-resistant, right? Because probably if you challenge them with
02:15:27.080
glucose immediately, they would have hyperglycemia. Physiologically, their muscles probably would,
02:15:32.280
in the short moment, say, hey, I don't want this stuff. Save every gram of that for the brain.
02:15:38.520
But presumably, if you refed them carbs for three days, they'd probably be as insulin-sensitive as
02:15:42.920
they'd ever been. Right. So I mean, this is one of the reasons why I think you're right. But I think
02:15:49.000
maybe what Shulman or Randall would say is that the reason for the lack of response to the transport
02:15:56.920
of glucose is that the system has now been downset by virtue of the high ambient free fatty acids,
02:16:03.560
and it may take some time to... Interesting. So you're thinking that could be the
02:16:07.320
short-term signal. Correct. And that takes time. That's why, again, I don't do this for a living.
02:16:12.600
I mean, you would know this. But why people are encouraged not to restrict their carbohydrates
02:16:18.600
prior to having a glucose tolerance test, for example. Right.
02:16:22.040
Because you can manipulate the system in the way that you just mentioned.
02:16:26.440
Rudy, I could sit here and talk about this stuff all night long, but
02:16:29.560
your wife will probably be pissed off that I kept you here all night. So maybe not. Maybe she's
02:16:34.120
actually enjoying the fact that you're right. Yeah, yeah, yeah. This has been super interesting.
02:16:39.000
You're really one of the most thoughtful people I've ever spoken to on this topic. And I think
02:16:43.640
there are a lot of areas where we don't necessarily see eye to eye clinically, which again, that sounds
02:16:48.520
like a much more harsh statement than it is. I just think we look at the world a little differently on
02:16:54.120
You're a hammer looking for a nail, and I'm kind of a general contractor looking for everything in sight.
02:16:59.640
I mean, I think it's interesting. I think your FTO example is a great example. I mean,
02:17:03.800
if I were tackling this problem, and I'm glad I'm not, I'd be wanting to understand the
02:17:08.600
environmental trigger. Is it the cigarette that's causing lung cancer? You're trying to solve a
02:17:13.160
different problem, which is, why is it that only some people get lung cancer when they smoke?
02:17:18.520
And those people, before the adage of the invention of cigarettes, would have never got lung cancer.
02:17:23.720
But now that these cigarettes are here, probably can't do much about it. Let's figure out who they are.
02:17:28.200
And not just for that reason. I mean, just as an intellectual question, I find it very intriguing.
02:17:34.760
But knowledge of whatever would lead a person who smokes not to get lung cancer,
02:17:41.640
it would be very nice to know what that is, that whatever that biology is, for many,
02:17:47.240
many reasons, not just related necessarily to lung cancer. And I see the issue of the
02:17:53.880
consequences of a genetic variant, very prevalent in the population, which predisposes some individuals
02:18:00.520
to the environmental consequences and others not. If we knew what that mechanism is,
02:18:05.640
is there's no reason to believe that at some point we might not be able to manipulate it,
02:18:10.920
not only in service of those who have the genetic variant, but others who might benefit from
02:18:19.480
Yeah. I mean, that makes a lot of sense. And you've given me some great pearls over the years.
02:18:25.160
I remember you, I think it was one night at dinner when you, me, Mike Rosenbaum were playing patty
02:18:31.880
cakes and it somehow came up that in your 10 to 20% weight reduced subjects,
02:18:37.080
a little bit of T3 could overcome some of the deficit. And I remember having this eureka moment
02:18:42.120
because I was like, wait a minute, all these patients I see that lose weight have a reverse
02:18:46.360
T3 spike. That would exactly explain why giving them T3 rather than T4 would address the problem.
02:18:53.480
You give a patient with high reverse T3, T4, you're just, you're making them worse,
02:18:58.040
but you give them T3, you can bypass it. So I'm incredibly grateful to you,
02:19:03.240
to your work and for your friendship. So thank you very much. Thank you.
02:19:09.560
You can find all of this information and more at peteratiamd.com forward slash podcast.
02:19:14.680
There you'll find the show notes, readings and links related to this episode.
02:19:18.840
You can also find my blog and the nerd safari at peteratiamd.com. What's a nerd safari you ask?
02:19:24.920
Just click on the link at the top of the site to learn more. Maybe the simplest thing to do is to
02:19:29.000
sign up for my subjectively non-lame once a week email, where I'll update you on what I've been up
02:19:33.640
to, the most interesting papers I've read and all things related to longevity, science, performance,
02:19:38.920
sleep, et cetera. On social, you can find me on Twitter, Instagram, and Facebook, all with the ID,
02:19:44.440
peteratiamd. But usually Twitter is the best way to reach me to share your questions and comments.
02:19:49.640
Now for the obligatory disclaimer, this podcast is for general informational purposes only and does
02:19:54.120
not constitute the practice of medicine, nursing, or other professional healthcare services,
02:19:59.000
including the giving of medical advice. And note, no doctor patient relationship is formed.
02:20:04.520
The use of this information and the materials linked to the podcast is at the user's own risk.
02:20:09.320
The content of this podcast is not intended to be a substitute for professional medical advice,
02:20:13.880
diagnoses, or treatment. Users should not disregard or delay in obtaining medical advice for any medical
02:20:19.400
condition they have and should seek the assistance of their healthcare professionals for any such
02:20:23.960
conditions. Lastly, and perhaps most importantly, I take conflicts of interest very seriously. For all
02:20:29.800
of my disclosures, the companies I invest in and or advise, please visit peteratiamd.com forward slash about.